<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_CSBJ870 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Comput Struct Biotechnol J</journal-id><journal-id journal-id-type="iso-abbrev">Comput Struct Biotechnol J</journal-id><journal-title-group><journal-title>Computational and Structural Biotechnology Journal</journal-title></journal-title-group><issn pub-type="epub">2001-0370</issn><publisher><publisher-name>Research Network of Computational and Structural Biotechnology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7905183</article-id><article-id pub-id-type="pii">S2001-0370(21)00054-4</article-id><article-id pub-id-type="doi">10.1016/j.csbj.2021.02.003</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Uncharted territories in the discovery of antifungal and antivirulence natural products from bacteria</article-title></title-group><contrib-group><contrib contrib-type="author" id="au005"><name><surname>Vij</surname><given-names>Raghav</given-names></name><xref rid="af005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au010"><name><surname>Hube</surname><given-names>Bernhard</given-names></name><xref rid="af005" ref-type="aff">a</xref><xref rid="af010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au015"><name><surname>Brunke</surname><given-names>Sascha</given-names></name><email>sascha.brunke@leibniz-hki.de</email><xref rid="af005" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#x0204e;</xref></contrib><aff id="af005"><label>a</label>Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology &#x02013; Hans Knoell Institute Jena (HKI), Germany</aff><aff id="af010"><label>b</label>Institute of Microbiology, Friedrich Schiller University, Jena, Germany</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x0204e;</label>Corresponding author. <email>sascha.brunke@leibniz-hki.de</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>11</day><month>2</month><year>2021</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>11</day><month>2</month><year>2021</year></pub-date><volume>19</volume><fpage>1244</fpage><lpage>1252</lpage><history><date date-type="received"><day>27</day><month>10</month><year>2020</year></date><date date-type="rev-recd"><day>2</day><month>2</month><year>2021</year></date><date date-type="accepted"><day>2</day><month>2</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 The Authors</copyright-statement><copyright-year>2021</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract id="ab005"><p>Many fungi can cause deadly diseases in humans, and nearly every human will suffer from some kind of fungal infection in their lives. Only few antifungals are available, and some of these fail to treat intrinsically resistant species and the ever-increasing number of fungal strains that have acquired resistance. In nature, bacteria and fungi display versatile interactions that range from friendly co-existence to predation. The first antifungal drugs, nystatin and amphotericin B, were discovered in bacteria as mediators of such interactions, and bacteria continue to be an important source of antifungals. To learn more about the ecological bacterial-fungal interactions that drive the evolution of natural products and exploit them, we need to identify environments where such interactions are pronounced, and diverse. Here, we systematically analyze historic and recent developments in this field to identify potentially under-investigated niches and resources. We also discuss alternative strategies to treat fungal infections by utilizing the antagonistic potential of bacteria to target fungal stress pathways and virulence factors, and thereby suppress the evolution of antifungal resistance.</p></abstract><kwd-group id="kg005"><title>Keywords</title><kwd>Antifungal</kwd><kwd>Antivirulence</kwd><kwd>Natural products</kwd><kwd>Fungal pathogens</kwd><kwd>Biosynthetic gene clusters</kwd></kwd-group></article-meta></front><body><sec id="s0005"><label>1</label><title>Introduction</title><p id="p0005">Of the myriad of fungal species which form critical components of our ecosystem, nearly 600 are known to infect humans <xref rid="b0005" ref-type="bibr">[1]</xref>. Amongst these, <italic>Candida</italic>, <italic>Aspergillus,</italic> and <italic>Cryptococcus</italic> species can be associated with high morbidity and mortality in patients, particularly such with an impaired immune system. An increase in the population at risk of invasive fungal infections, coupled with emerging antifungal resistance renders pathogenic fungi an eminent threat to public health <xref rid="b0010" ref-type="bibr">[2]</xref>, <xref rid="b0015" ref-type="bibr">[3]</xref>, <xref rid="b0020" ref-type="bibr">[4]</xref>. Some opportunistic fungi like <italic>Candida auris</italic> and <italic>Lomentospora prolificans</italic> are naturally resistant to many antimycotics <xref rid="b0025" ref-type="bibr">[5]</xref>, <xref rid="b0030" ref-type="bibr">[6]</xref>. Other species, like <italic>C. glabrata</italic>, show a high intrinsic resistance to specific antifungals like azoles, and some further species, including <italic>C. albicans</italic>, can acquire resistance to antifungals upon exposure, for instance during prophylactic treatments <xref rid="b0035" ref-type="bibr">[7]</xref>. Yet, there are only a few classes of antifungal drug classes approved and available for treatment of invasive infections caused by a broad spectrum of pathogenic fungi. Altogether, these factors have contributed to a rise in the incidence of infections by drug-resistant fungal strains <xref rid="b0040" ref-type="bibr">[8]</xref>, and call for urgent action in the search for new antifungal therapeutics with distinct mechanisms of action <xref rid="b0045" ref-type="bibr">[9]</xref>.</p><p id="p0010">Many natural products with antimicrobial activities have been identified among microbial natural products. In the ecological context, these compounds defend microbial competitors during interaction of different bacterial and fungal species. In this article, we will review some recent advances in the investigation of bacterial and fungal interaction, and the potential to exploit inter-kingdom molecular communication to develop novel antifungal therapies.</p><p id="p0015">Even before humankind identified microbes as the cause of infectious disease, molds were reportedly used to treat sores and wounds susceptible to bacterial infections in ancient Egypt, China, Greece, and the Roman Empire <xref rid="b0050" ref-type="bibr">[10]</xref>. As the scientific community began a systematic search for antimicrobial agents, pioneers in microbiology, including John Lister, described the potential of discovering antibiotics by exploiting the interactions between bacteria and fungi <xref rid="b0055" ref-type="bibr">[11]</xref>. In 1928, these efforts culminated in a paradigm-shifting discovery when Alexander Fleming serendipitously observed that a mold contaminant, later identified as <italic>Penicillium notatum</italic>, was able to lyse colonies of the bacterium <italic>Staphylococcus aureus</italic>
<xref rid="b0060" ref-type="bibr">[12]</xref>. Later, the chemists Chain and Florey worked together to isolate the antimicrobial agent Penicillin. Since then, scientists have frequently looked for natural products secreted by microorganisms to identify novel compounds and scaffolds which can be used to treat maladies ranging from cancer to fungal infections (reviewed in <xref rid="b0065" ref-type="bibr">[13]</xref>, <xref rid="b0070" ref-type="bibr">[14]</xref>).</p><p id="p0020">The notable contributions of Elizabeth Lee Hazen and Rachel Brown as pioneering women in science (see <xref rid="b0075" ref-type="bibr">[15]</xref> for a biography) led to the development of the first antifungal drug to be prescribed to humans that was significantly less toxic than previous substances. Their collaboration involved a systematic attempt to survey the soil for organisms that inhibit the growth of deadly fungi, the subsequent isolation of active compounds from crude extracts, followed by an evaluation of toxicity for the promising compounds in model organisms. This approach led to the discovery of the polyene antifungal nystatin, that is secreted by <italic>Streptomyces noursei</italic>
<xref rid="b0080" ref-type="bibr">[16]</xref>. Polyenes bind to ergosterol, an essential sterol in the fungal cell membrane, and kill fungal cells through mechanisms briefly discussed later in this review. Amphotericin B (AmB), secreted by <italic>S. nodosus</italic>
<xref rid="b0085" ref-type="bibr">[17]</xref>, is another prominent antifungal polyene that acts on the fungal membrane in a similar manner. While AmB is a potent antifungal with broad-spectrum activity and remains essential for treating invasive fungal infections, polyenes also bind to cholesterol in mammalian membranes and thereby often exerts toxic side effects. Synthetic and semi-synthetic drugs like azoles and echinocandins that target the biosynthesis of fungal cell membranes and the cell-wall, respectively, have emerged as less toxic and frequently prescribed alternatives.</p><p id="p0025">There are only few antifungals in development. Notable compounds in the antifungal pipeline broadly fall into two categories: compounds that have novel mechanisms of action and those that are reformulations or modifications of existing and well-established drug classes (reviewed in <xref rid="b0090" ref-type="bibr">[18]</xref>, <xref rid="b0095" ref-type="bibr">[19]</xref>). Promising synthetic compounds that fall into the latter category include the azoles BB2603, PC945, VT-1161, and VT-1598. Similarly, rezafungin <xref rid="b0100" ref-type="bibr">[20]</xref> and SCY-078 <xref rid="b0105" ref-type="bibr">[21]</xref> are echinocandins, synthetic derivatives of glucan synthesis inhibitors that are secreted naturally by certain fungi. APX001, Olorfim and VL-2397 are novel drugs that inhibit fungal growth by targeting diverse cellular processes. Olorfim inhibits nucleotide biosynthesis <xref rid="b0110" ref-type="bibr">[22]</xref>, while VL-2397 chelates iron that is essential for fungal survival in the host and is secreted by the fungus <italic>Acremonium persicinum</italic>
<xref rid="b0115" ref-type="bibr">[23]</xref>, and APX001 (also called fosmanogepix) targets GPI anchors on the cell wall of fungi (reviewed in <xref rid="b0120" ref-type="bibr">[24]</xref>). The repurposing of the synthetic anti-depressant sertraline for treating cryptococcal meningitis is currently being explored, as it was found to perturb fungal protein translation and significantly lower the fungal burden in the murine brain <xref rid="b0125" ref-type="bibr">[25]</xref>. Nikkomycin Z is one amongst the very few bacterial natural products in the antifungal pipeline, and highlights the potential for discovery of compounds from bacteria that target distinct mechanisms. The compound, first isolated from <italic>S. tendae</italic>
<xref rid="b0130" ref-type="bibr">[26]</xref>, inhibits the biosynthesis of chitin, a critical component of the fungal cell wall. Nikkomycin Z has shown promising success during early clinical trials (phase I) against coccidioidomycosis <xref rid="b0135" ref-type="bibr">[27]</xref>. Further trials were terminated due to a lack of funding <xref rid="b0140" ref-type="bibr">[28]</xref>.</p><p id="p0030">By theoretical estimates there are approximately 5 million species of fungi <xref rid="b0145" ref-type="bibr">[29]</xref>, <xref rid="b0150" ref-type="bibr">[30]</xref>, and 1 trillion species of bacteria <xref rid="b0155" ref-type="bibr">[31]</xref>, <xref rid="b0160" ref-type="bibr">[32]</xref>, although these estimates remain controversial. Given these numbers, in the diverse ecological niches that bacteria and fungi co-inhabit virtually infinite combinations of interactions are possible. Bacteria and fungi can influence each other&#x02019;s physical environment, growth, and morphology. They can cooperate with each other, be dependent on one another and/or have an antagonistic relationship. These interactions can have a significant effect on other organisms, including plants and humans. The diversity of their interactions, as well as their effect on human health have been exhaustively reviewed in <xref rid="b0165" ref-type="bibr">[33]</xref>, <xref rid="b0170" ref-type="bibr">[34]</xref>, <xref rid="b0175" ref-type="bibr">[35]</xref>, <xref rid="b0180" ref-type="bibr">[36]</xref>, <xref rid="b0185" ref-type="bibr">[37]</xref>.</p><p id="p0035">Natural products are primarily non-essential substances biosynthesized by bacteria, fungi or plants which are often bioactive and can play a crucial role in ecological interactions as communication signals or chemical weapons for predation or as defense against it. Molecules with antifungal activity are usually natural products, generally produced by bacteria <italic>via</italic> biosynthetic pathways that are encoded by complex biosynthetic gene clusters (BGCs).</p><p id="p0040">For this review, we used systematic and computational approaches <xref rid="b0190" ref-type="bibr">[38]</xref> to filter the nearly 6,500 papers in the literature on antifungals derived from bacteria and tried to define trends. The results from an NCBI query, &#x0201c;antifungal[mesh] AND bacteria[mesh] AND journal article[publication type]&#x0201d;, indicated a notable increase of interest in the field over the last decades. This raises the crucial question: Why has this large body of literature and intense research resulted in the discovery of only one class of approved antifungals, polyenes, from bacteria?</p><p id="p0045">Keeping aside the enormous challenges of developing new antifungal agents for use in patients <xref rid="b0045" ref-type="bibr">[9]</xref>, <xref rid="b0195" ref-type="bibr">[39]</xref>, in this review, we will discuss the rationale for studying the diversity, and the complexity, of bacterial-fungal interaction as a source of inspiration for antimycotic drug discovery.</p><sec id="s0010"><label>1.1</label><title>Uncharted territories in the prokaryote kingdom</title><p id="p0050">To get a rudimentary estimate of the taxonomic breadth of bacterial species covered in our literature search of bacteria-derived antifungals, we linked our NCBI PubMed query to information from the NCBI Taxonomy database, using the &#x0201c;rentrez&#x0201d; package in R <xref rid="b0200" ref-type="bibr">[40]</xref>. After removing the ambiguous taxonomy information and selecting only bacterial species, we plotted a heat tree of bacterial families linked to our query (<xref rid="f0005" ref-type="fig">Fig. 1</xref>) using the packages &#x0201c;taxa&#x0201d; and &#x0201c;metacoder&#x0201d; <xref rid="b0205" ref-type="bibr">[41]</xref>, <xref rid="b0210" ref-type="bibr">[42]</xref>. In this tree, the labeled nodes represent bacterial taxomic units, down to families at the leaves, for which we found literature on antifungal activities. Their relative distance corresponds to the degree of taxonomic relationship, and the color and size depicts the number of species for which literature entries exist in PubMed. The tree thereby essentially illustrates the taxonomic distribution of bacteria which have been connected to antifungal research in the past. The wide-spread branching of the heat tree indicates that there is interest and potential for antifungal compounds widely across the bacteria kingdom, but clear hot-spots are visible in certain branches (<xref rid="f0005" ref-type="fig">Fig. 1</xref>).<fig id="f0005"><label>Fig. 1</label><caption><p>Heat tree depicting the taxonomic distribution of bacterial species that were linked to antifungal research by a PubMed literature search. Each node represents a taxonomic unit, down to families at the leaves. The color and the size of each node indicate the number of species with publications on the topic of antifungal compounds, summed up as operational taxonomic unit (OTUs). For example, Streptomycetaceae are well explored in the literature for their antifungal property with publications on many species, while Myxococcaceae may be represent a yet untapped source for novel drugs (highlighted here with black boxes).</p></caption><graphic xlink:href="gr1"/></fig></p><p id="p0055">There are two factors that contribute to this unequal distribution of bacterial species abundance in the heat tree of scientific attention (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). One is that that there are large variations in the diversity of BGCs among prokaryotes <xref rid="b0215" ref-type="bibr">[43]</xref>. Some clades intrinsically have a higher genomic potential to synthesize natural products, and their ecological interactions drive the evolution of molecules that allow them to adapt to their environment <xref rid="b0215" ref-type="bibr">[43]</xref>, <xref rid="b0220" ref-type="bibr">[44]</xref>, <xref rid="b0225" ref-type="bibr">[45]</xref>. A recent study revealed that bacteria found in soils from similar biomes are likely to secrete similar molecules <xref rid="b0220" ref-type="bibr">[44]</xref>, <xref rid="b0230" ref-type="bibr">[46]</xref>, <xref rid="b0235" ref-type="bibr">[47]</xref>, and the biome, e.g. arid <italic>vs</italic> swamp lands, can strongly influence the biosynthetic potential. In the arid soils for example, a high diversity was found that was likely driven by the high abundance of actinobacteria <xref rid="b0230" ref-type="bibr">[46]</xref>. Within the actinobacteria, certain families like Streptomycetales are already sources of important antifungals like AmB, nystatin and nikkomycin Z, and are known for their abundant and genetically very diverse BGCs <xref rid="b0240" ref-type="bibr">[48]</xref>, rendering them promising model organisms. Antibiotic production is regulated during their life-cycle to defend the sessile Streptomycetales when they release molecules that attract motile prey (reviewed in <xref rid="b0245" ref-type="bibr">[49]</xref>, <xref rid="b0250" ref-type="bibr">[50]</xref>). Streptomycetales are not only found in soil, but in diverse ecological niches with different competitors, including fungi. Therefore, it is not surprising that the family Streptomycetales presents a densely populated node in the heat tree (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). In contrast, in other clades like the Corynebacteriales, the BGCs are generally conserved, and the members seem to have undergone genomic reduction <xref rid="b0255" ref-type="bibr">[51]</xref>. Species within this clade include human microbiome strains and mycobacteria, which may have conserved BGCs adapted to survival in the host (<xref rid="b0240" ref-type="bibr">[48]</xref>, reviewed in <xref rid="bib766" ref-type="bibr">[154]</xref>). This decreased genomic potential is likely the reason why the associated nodes are comparatively less dense (<xref rid="f0005" ref-type="fig">Fig. 1</xref>).</p><p id="p0060">The second factor for unexpectedly less dense branches in the tree are the clades that have diverse BGCs, but these have not been exhaustively explored. For instance, in our literature analysis, we found that only a few studies described antifungal molecules from Myxococcales species (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). Myxobacteria are a fascinating group of bacteria, defined by their intense social interactions, and their ability to form multicellular fruiting bodies when they are under stress (reviewed in <xref rid="b0260" ref-type="bibr">[52]</xref>). Presumably because of their social lifestyle, Myxobacteria have evolved various mechanisms to communicate with each other, and with other species in their habitat. They are adept in outcompeting other microbes to conquer common resources, and some even predate on other microbes (reviewed in <xref rid="b0265" ref-type="bibr">[53]</xref>, <xref rid="b0270" ref-type="bibr">[54]</xref>). To prey on fungi and bacteria, myxobacteria rely on a combination of cell wall degrading enzymes, and notably, an array of antibiotic secondary metabolites <xref rid="b0275" ref-type="bibr">[55]</xref>, <xref rid="b0280" ref-type="bibr">[56]</xref>, <xref rid="b0285" ref-type="bibr">[57]</xref>, <xref rid="b0290" ref-type="bibr">[58]</xref>. <italic>In vitro</italic>, diverse myxobacteria can prey on <italic>C. albicans</italic>
<xref rid="b0295" ref-type="bibr">[59]</xref>, and promising novel antifungal molecules, like ambruticin, have been isolated from them <xref rid="b0300" ref-type="bibr">[60]</xref>, <xref rid="b0305" ref-type="bibr">[61]</xref>. A study by Hoffman <italic>et al</italic> provided an insightful snapshot into the metabolites secreted by nearly ~2300 myxobacteria, and predicted that it is more likely to find unique metabolite profiles in more distantly related myxobacterial genera <xref rid="b0310" ref-type="bibr">[62]</xref>. This provides a rationale and motivates a deeper exploration of new genera during the search for novel antifungal compounds <xref rid="b0315" ref-type="bibr">[63]</xref>.</p><p id="p0065">However, the observations made by field microbiologists in the 1960s <xref rid="b0320" ref-type="bibr">[64]</xref> are relevant even today, as a vast majority of bacteria remain unculturable or grow very slowly under laboratory conditions. This phenomenon has been described as &#x0201c;the great plate anomaly&#x0201d; <xref rid="b0325" ref-type="bibr">[65]</xref>. Through advances in the isolation and culturing of new bacteria <xref rid="b0330" ref-type="bibr">[66]</xref>, <xref rid="b0335" ref-type="bibr">[67]</xref>, <xref rid="b0340" ref-type="bibr">[68]</xref>, <xref rid="b0345" ref-type="bibr">[69]</xref>, <xref rid="b0350" ref-type="bibr">[70]</xref>, and metagenomic approaches of expressing genes mined from unculturable bacteria in model organisms (reviewed in <xref rid="b0355" ref-type="bibr">[71]</xref>), it is now possible to discover new metabolites from yet untapped bacteria. In the case of slow growing myxobacteria, genetic engineering approaches have facilitated the expression of myxobacterial BGCs in model organisms like <italic>Pseudomonas putid</italic>a, enabling the isolation of novel antibiotic gene products <xref rid="b0360" ref-type="bibr">[72]</xref>, <xref rid="b0365" ref-type="bibr">[73]</xref>. Finally, given the interest in new myxobacterial species <xref rid="b0310" ref-type="bibr">[62]</xref>, 16s ribosome sequencing of viable but non-culturable isolates has provided insights into their diversity <xref rid="b0370" ref-type="bibr">[74]</xref>, <xref rid="b0375" ref-type="bibr">[75]</xref>, <xref rid="b0380" ref-type="bibr">[76]</xref>, <xref rid="b0385" ref-type="bibr">[77]</xref>. Transferring the nutrient requirements of related culturable bacteria, and through the development of metagenomic tools, researchers hope to exploit the biosynthetic potential of suborders like Sorangiineae soon <xref rid="b0390" ref-type="bibr">[78]</xref>, <xref rid="b0395" ref-type="bibr">[79]</xref>.</p><p id="p0070">A broad variability in the BGC diversity of bacterial clades has been observed in many previous studies, but there seems to be no clear consensus in the field so far whether phylogeny and biosynthetic potential correlate <xref rid="b0215" ref-type="bibr">[43]</xref>, <xref rid="b0255" ref-type="bibr">[51]</xref>, <xref rid="b0310" ref-type="bibr">[62]</xref>, and thus, whether it is more promising to search for new substances taxonomically distant from known producers, or close by. A heat tree like <xref rid="f0005" ref-type="fig">Fig. 1</xref> can be used as a kind of map that shows the known clades of well-investigated producers like actinobacteria, and the uncharted territories which contain islands of prokaryote families with antifungals awaiting their discovery.</p></sec><sec id="s0015"><label>1.2</label><title>A diverse and hidden arsenal of natural products from bacteria</title><p id="p0075">A closer look at the synthesis of AmB by the actinobacterium, <italic>S. nodosus</italic> shows that some bacteria invest immense efforts to synthesize and secrete small molecules that specifically affect fungal competitors<italic>.</italic> Polyketide synthase (PKS) modular enzymes encoded by six large PKS genes in the AmB gene cluster facilitate specific additions and substitutions to tailor the macrolide backbone of AmB. Two cytochrome P450 enzymes modify the precursor molecule, and several enzymes synthesize and attach a mycosamine moiety that is essential for binding to ergosterol <xref rid="b0400" ref-type="bibr">[80]</xref>, <xref rid="b0405" ref-type="bibr">[81]</xref>. The molecule is transported by two ABC transporter proteins encoded in the gene cluster, and notably, this complex biochemical pathway is orchestrated by several regulatory factors <xref rid="b0410" ref-type="bibr">[82]</xref>. The resultant molecule AmB has the exact configuration required to bind and sequester ergosterol, an essential component of the fungal cell membrane <xref rid="b0415" ref-type="bibr">[83]</xref>, <xref rid="b0420" ref-type="bibr">[84]</xref>, which permeabilizes it to causes rapid efflux of ions from the fungal cytosol <xref rid="b0425" ref-type="bibr">[85]</xref>, <xref rid="b0430" ref-type="bibr">[86]</xref>. The combinatorial effects of AmB lead to rapid fungal cell death, which makes it an important antifungal agent to this day. <italic>S. nodosus</italic> has even more to offer, as its AmB gene cluster also synthesizes amphotericin A, which differs from AmB only by a single bond in place of a double bond <xref rid="b0085" ref-type="bibr">[17]</xref>, <xref rid="b0435" ref-type="bibr">[87]</xref>. It is postulated that the kinetic competition between different modules of PKS assembly line lead to the formation of both, amphotericin A and B <xref rid="b0400" ref-type="bibr">[80]</xref>.</p><p id="p0080">As hinted at by the two forms of amphotericin, bacteria use several mechanisms to diversify their repertoire of natural products (reviewed in <xref rid="b0440" ref-type="bibr">[88]</xref>, <xref rid="b0445" ref-type="bibr">[89]</xref>). The organization of genes into BGCs, and the modular nature of enzyme complexes like PKS and non-ribosomal peptide synthetases (NRPS) offer an intrinsic versatility. Entire gene clusters can be horizontally transferred from one species to another. Under selection pressure, or due to genetic drift genes in BGCs undergo substitutions, deletions, rearrangements, and duplications, that result in the synthesis of molecules with different properties and/or functions <xref rid="b0450" ref-type="bibr">[90]</xref>. For instance, across the actinobacterium clade, there is evidence of diversification of the polyene BGC, particularly at the acetyl-transferase domain, that has led to the synthesis of structurally distinguishable molecules like nystatin, amphotericin, pimaricin, and selvamicin <xref rid="b0400" ref-type="bibr">[80]</xref>, <xref rid="b0450" ref-type="bibr">[90]</xref>, <xref rid="b0455" ref-type="bibr">[91]</xref>, <xref rid="b0460" ref-type="bibr">[92]</xref>, <xref rid="b0465" ref-type="bibr">[93]</xref>. This diversity can be exploited in drug discovery: The structural differences between selvamicin and nystatin result in significant shifts of properties, such as solubility or the mechanism of action <xref rid="b0455" ref-type="bibr">[91]</xref>.</p><p id="p0085">In 2002, the complete genome sequence of the antibiotic producer, <italic>S. coelicolor</italic> A3(2) was published <xref rid="b0470" ref-type="bibr">[94]</xref>. An incongruity was observed when the whole genomic sequence of the bacterium was examined and researchers noticed that while there were nearly &#x02248;23 BGCs, only a dozen natural products were produced or had been isolated from the supernatant of lab cultures. The discovery of &#x0201c;cryptic&#x0201d; or &#x0201c;silent&#x0201d; gene clusters across the bacterial (and fungal) kingdom revealed that microbes have far greater genomic potential for the synthesis of natural products than was previously recognized. Sophisticated computational methods have kept pace with the ever-expanding repositories of bacterial genome sequences. Genome mining tools are able to predict the biosynthetic potential of species, and identify promising gene clusters that maybe hidden (reviewed in <xref rid="b0475" ref-type="bibr">[95]</xref>). For example, a recent metagenomics study described the high biosynthetic potential from unexplored clades in the soil, including unculturable and previously unknown Acidobacteria and species of the candidate phylum Rokubacteria (<xref rid="f0005" ref-type="fig">Fig. 1</xref>) <xref rid="b0480" ref-type="bibr">[96]</xref>. Metatransciptomics showed that the expression of the BGCs in these bacteria varied greatly over time, and was influenced by the presence of substrates like glucose, methanol, and water <xref rid="b0480" ref-type="bibr">[96]</xref>.</p><p id="p0090">The natural product biosynthetic pathways in bacteria are complex and energetically expensive, and therefore it makes sense if they are not expressed in the absence of microbial interaction partners. In a pioneering study, Schroeckh <italic>et al</italic> found that co-cultures of <italic>Aspergillus fumigatus</italic> and soil actinomycetes activated silent gene clusters in fungi, which led to the synthesis of previously unknown antibacterial metabolites <xref rid="b0485" ref-type="bibr">[97]</xref>. A similar rationale has also led to the discovery of jagaricin, an antifungal compound secreted by <italic>Janthinobacterium agaricidamnosum</italic> (see family Oxalobacteraceae in heat tree, <xref rid="f0005" ref-type="fig">Fig. 1</xref>), a bacterium that causes soft rot disease in button mushrooms, <italic>Agaricus bisporus</italic>
<xref rid="b0490" ref-type="bibr">[98]</xref>. A genome mining approach revealed the potential to secrete antifungal metabolites, but these BCGs were not expressed in standard cultures <xref rid="b0495" ref-type="bibr">[99]</xref>. Graupner <italic>et. al</italic> cultured the bacterium quasi-naturally on mushroom slices, and thereby induced the expression of the cryptic gene cluster that allowed production of jagaracin, which in turn was detected by imaging mass spectrometry <xref rid="b0495" ref-type="bibr">[99]</xref>. Notably, jagaricin exhibited a broad spectrum of activity against plant fungal pathogens, making it a promising starting point for a compound that may be useful in agriculture <xref rid="b0500" ref-type="bibr">[100]</xref>.</p><p id="p0095">Several studies that considered ecological interactions as the driver of evolution of BGCs have advanced the discovery of antifungals. Certain bacteria, like species in the Pseudonocardiaceae and Streptomycetaceae families (see noticeably dense nodes, <xref rid="f0005" ref-type="fig">Fig. 1</xref>), protect ants from fungal infections <xref rid="b0505" ref-type="bibr">[101]</xref>. Based on this rationale, Haeder <italic>et al.</italic> sought to isolate antifungal molecules from bacteria associated with leaf-cutter ant colonies <xref rid="b0510" ref-type="bibr">[102]</xref>. The bacteria were found to synthesize candicidin, a polyene macrolide, that had potent activity against the fungal ant pathogen <italic>Escovopsis</italic> sp., but only little effect on the growth of symbiotic fungi <xref rid="b0510" ref-type="bibr">[102]</xref>. Isolation of bacteria from ant colonies also led to the discovery of several other antifungal molecules, including selvamicin and dentigerumycin <xref rid="b0455" ref-type="bibr">[91]</xref>, <xref rid="b0515" ref-type="bibr">[103]</xref>, <xref rid="b0520" ref-type="bibr">[104]</xref>, <xref rid="b0525" ref-type="bibr">[105]</xref>. Clearly, ecological niches where fungi and bacteria closely interact, like the soil <xref rid="b0230" ref-type="bibr">[46]</xref>, <xref rid="b0530" ref-type="bibr">[106]</xref>, lichen <xref rid="b0535" ref-type="bibr">[107]</xref>, and insect microbiomes <xref rid="b0540" ref-type="bibr">[108]</xref>, <xref rid="b0545" ref-type="bibr">[109]</xref>, are promising sources of antifungal molecules (reviewed in <xref rid="b0185" ref-type="bibr">[37]</xref>). A combination of metabolomic, transcriptomic, and metagenomic data therefore is a promising avenue to compare networks of microbial interactions in different biomes (reviewed in <xref rid="b0550" ref-type="bibr">[110]</xref>) &#x02013; and in biomes that are enriched in bacteria-fungi interactions, future discoveries of new antifungal compounds are very likely.</p></sec><sec id="s0020"><label>1.3</label><title>Bacterial natural products to target fungal stress responses</title><p id="p0100">Conventionally, our rationale in the search for antifungal drugs is limited to screening for molecules that have potent fungicidal or fungistatic activity. The goal therein is to discover compounds so potent, that they decimate entire populations of pathogens during infection. Realistically, however, through various mechanisms, fungi develop resistance (reviewed in <xref rid="b0555" ref-type="bibr">[111]</xref>) or gain tolerance in the host (reviewed in <xref rid="b0560" ref-type="bibr">[112]</xref>). One measure to oppose that are combination therapies, the gold standard of anti-infective therapy is the combinatorial treatment against tuberculosis that targets up to four distinct cellular processes to kill the bacteria and prevent the emergence of resistance. However, most antifungal drugs in use today only target single cellular processes, like cell wall or membrane synthesis and repair, and development of resistance is accordingly common.</p><p id="p0105">Bacteria in interaction with fungi should face the same problem of their targets becoming resistant, and it seems likely that microbes have evolved strategies to lower the rate of evolutionary resistance development in fungi. The numerous BGCs bacteria often encode may be one of them, as the synthesized plethora of molecules may sometimes act synergistically and target diverse cellular processes, to give the organism a competitive advantage (discussed in <xref rid="b0565" ref-type="bibr">[113]</xref>, <xref rid="b0570" ref-type="bibr">[114]</xref>). It may be worthwhile, therefore, to again turn to microbial interactions for the discovery of compounds that suppress the evolution of resistance.</p><p id="p0110">Fk506 <xref rid="b0575" ref-type="bibr">[115]</xref> and geldanamycin <xref rid="b0580" ref-type="bibr">[116]</xref> were discovered and isolated from actinobacteria, while screening for drugs with antimicrobial properties. Later studies found that they target cellular stress response conserved across eukaryotes, and since then they have been studied extensively for their immunosuppressive (FK506) and anti-cancer (geldanamycin) potential in humans. The need for antifungal drugs with novel mechanisms has led researchers to reexamine and repurpose these drugs for their antifungal potential.</p><p id="p0115">For example, the immunosuppressant FK506 binds to the protein FKB12, such that the FK506-FKB12 complex inhibits Calcineurin, a phosphatase required for T-cell activation in mammals <xref rid="b0585" ref-type="bibr">[117]</xref>. In pathogenic fungi like <italic>Cryptococcus neoformans</italic>, <italic>C. albicans</italic>, and <italic>A. fumigatus</italic>, its ortholog was found to be essential for virulence, thermotolerance, and antifungal drug tolerance, making it a promising drug target (reviewed in <xref rid="b0590" ref-type="bibr">[118]</xref>). Notably, FK506 also acts synergistically with antifungal drugs (reviewed in <xref rid="b0595" ref-type="bibr">[119]</xref>).</p><p id="p0120">One obvious hindrance in pursuing FK506 and geldanamycin for clinical use is their off-target and detrimental effects on mammalian cells. For instance, the immunosuppressive effects of FK506 could interfere with the patient&#x02019;s immune response to the fungal infection, and lead to poor outcomes, as was observed in a cryptococcosis murine model <xref rid="b0600" ref-type="bibr">[120]</xref>. To overcome this, structure&#x02013;activity based modeling approaches have been used to develop and identify new molecules that specifically target FKBP12 <xref rid="b0590" ref-type="bibr">[118]</xref>, <xref rid="b0600" ref-type="bibr">[120]</xref>, <xref rid="b0605" ref-type="bibr">[121]</xref>, <xref rid="b0610" ref-type="bibr">[122]</xref> in fungi, but that do not effect mammalian cells (reviewed in <xref rid="b0615" ref-type="bibr">[123]</xref>). A promising alternative is to use genome mining to identify similar biosynthetic gene clusters in bacteria, and identify fungal specific effector molecules. We may also discover novel molecules with unexpected targets and functions: The immunosuppressants FK506 and rapamycin are structurally related molecules synthesized by a gene clusters of similar origin, and both were discovered as novel antifungals, but they have very different modes of action <xref rid="b0450" ref-type="bibr">[90]</xref>, <xref rid="b0620" ref-type="bibr">[124]</xref>.</p><p id="p0125">Geldanamycin, is a potent and specific Hsp90 inhibitor that was also first isolated from bacteria <xref rid="b0580" ref-type="bibr">[116]</xref>. Hsp90 is a molecular chaperone that stabilizes proteins like calcineurin that are induced upon exposure to antifungal drugs, and it helps to stabilize fungal cells long enough for them accrue mutations that confer resistance <xref rid="b0625" ref-type="bibr">[125]</xref>, <xref rid="b0630" ref-type="bibr">[126]</xref>, <xref rid="b0635" ref-type="bibr">[127]</xref>. Combinatorial treatment of fungi with geldanamycin and azoles or echinocandins prevents the rapid selection of antifungal resistance <xref rid="b0640" ref-type="bibr">[128]</xref>. It remains to be seen whether the &#x0201c;evolution-suppressor&#x0201d; effect of these molecules that affect antifungal tolerance <italic>in vitro</italic> (and in murine models), also affects fungal competitors of the bacteria that secrete them in co-cultures or microbial communities. Bacteria that synthesize geldanamycin and similar molecules have been isolated from habitats ranging from marine worms to soil <xref rid="b0580" ref-type="bibr">[116]</xref>, <xref rid="b0645" ref-type="bibr">[129]</xref>, <xref rid="b0650" ref-type="bibr">[130]</xref>, and we may yet discover molecules that specifically target fungal pathogens of humans or plants, but not human cells.</p><p id="p0130">However, certain mechanisms of antifungal resistance may confer cross resistance to geldanamycin and FK506, particularly mutations that lead to an increase in drug efflux pump activity <xref rid="b0600" ref-type="bibr">[120]</xref>, <xref rid="b0630" ref-type="bibr">[126]</xref>. It is likely that this phenomenon will extend to compounds discovered by genome mining approaches that search for new bacterial BGCs. Another limitation in genome mining is that we cannot predict novel molecules from previously undescribed and unique gene clusters. Therefore, unbiased screening to discover new compounds from bacteria, possibly in co-cultures with fungi, remains relevant.</p></sec><sec id="s0025"><label>1.4</label><title>Bacterial natural products to disarm fungal virulence</title><p id="p0135">With gathering evidence on the detrimental impact of fungal dysbiosis on health, it becomes also crucial to think beyond the use of broad spectrum antifungals that detrimentally impact the mycobiome (<xref rid="b0655" ref-type="bibr">[131]</xref>, reviewed in <xref rid="b0660" ref-type="bibr">[132]</xref>). Most fungi that cause disease do so from opportunistic infections, and they use specific virulence factors to damage the host (reviewed in <xref rid="b0665" ref-type="bibr">[133]</xref>). An alternative to eradication of fungi is therefore to target their virulence factors. If these virulence factors are not essential for survival in the host, there should be no strong selective pressure, and this strategy would largely avoid the rapid development of resistant mutants.</p><p id="p0140">For example, <italic>C. albicans</italic> can switch between yeast and hyphae morphologies, and the hyphal form is associated with host cell invasion, damage and virulence. Therefore, <italic>C. albicans</italic> dimorphism is a notable target for antivirulence drugs (reviewed in <xref rid="b0670" ref-type="bibr">[134]</xref>, <xref rid="b0675" ref-type="bibr">[135]</xref>). A series of clinical observations from the 1980s, on the co-occurrences of bacteria and fungi in infections, first garnered an interest in the direct impact of such interactions on human health <xref rid="b0180" ref-type="bibr">[36]</xref>, <xref rid="b0680" ref-type="bibr">[136]</xref>. Following up on one such frequently co-occurring pair, Hogan <italic>et. al</italic> observed that <italic>P. aeruginosa</italic> and <italic>C. albicans</italic> influence each other&#x02019;s behavior <xref rid="b0685" ref-type="bibr">[137]</xref>, and these interactions affect the outcome of a mixed infection. Later they also discovered 3OC12HSL, a molecule secreted by <italic>P. aeruginosa</italic> that mimics the fungal quorum sensing molecule farnesol, and modulates <italic>C. albicans</italic> morphogenesis, but not growth <xref rid="b0690" ref-type="bibr">[138]</xref>. Molecules that target other important virulence attributes of <italic>C. albicans,</italic> including biofilm formation and fungal adhesion have also been discovered from bacteria (<xref rid="b0695" ref-type="bibr">[139]</xref>, <xref rid="b0700" ref-type="bibr">[140]</xref>, <xref rid="b0705" ref-type="bibr">[141]</xref> and reviewed in <xref rid="b0710" ref-type="bibr">[142]</xref>).</p><p id="p0145"><italic>C. neoformans</italic> and <italic>C. gattii</italic> can evade host defenses by forming a protective polysaccharide capsule, and a black-brown pigment called melanin. <italic>Cryptococcus</italic> species are commonly isolated from trees, soil, water, and pigeon stool, which first led researchers to examine their ecological interactions with bacteria (reviewed in <xref rid="b0715" ref-type="bibr">[143]</xref>), where they found numerous strains of bacteria from pigeons that inhibited <italic>Cryptococcus</italic> spp. growth. Mayer <italic>et al.</italic> investigated antivirulence effects of environmental isolates of <italic>Bacillus</italic> spp., which were found to inhibit cryptococcal melanin and capsule formation, but did not significantly alter its growth <xref rid="b0720" ref-type="bibr">[144]</xref>. The strain <italic>Bacillus&#x000a0;safensis</italic> also inhibited <italic>C. albicans</italic> filamentation, biofilm formation, and adhesion <xref rid="b0720" ref-type="bibr">[144]</xref>. Intriguingly, the authors did not find any small molecules secreted by the bacterium that affected virulence of <italic>C.&#x000a0;neoformans</italic>
<xref rid="b0720" ref-type="bibr">[144]</xref>. Instead, they found that the bacteria swarm and surround fungal cells, and their antivirulence effect is due to a cell&#x02013;cell contact mediated degradation of the fungal cell-wall polymer chitin <xref rid="b0720" ref-type="bibr">[144]</xref>. Other notable antivirulence targets include metalloproteases that allow <italic>C. neoformans</italic> cells to cross the blood brain barrier where they cause fatal meningitis (reviewed in <xref rid="b0725" ref-type="bibr">[145]</xref>).</p><p id="p0150">To take advantage of the many mechanisms bacteria use to dynamically suppress fungal virulence, there has been considerable interest in screening and identifying bacteria that can be used as live therapeutics. Numerous studies have indicated that <italic>Lactobacillus</italic> spp. can decrease mucosal <italic>Candida</italic> infections (reviewed in <xref rid="b0730" ref-type="bibr">[146]</xref>). Lactobacilli affect <italic>C. albicans</italic> in a contact-dependent manner, and secrete molecules ranging from hydrogen peroxide to proteins that degrade chitin, which then in combination affect hyphae and biofilm formation <xref rid="b0735" ref-type="bibr">[147]</xref>, <xref rid="b0740" ref-type="bibr">[148]</xref>. In the presence of <italic>L. rhamnosus</italic>, host epithelial cells associated with <italic>C. albicans</italic> cells are shed and at least some seem to die via apoptosis, which allows for the renewal and maintenance of the epithelial barrier <xref rid="b0745" ref-type="bibr">[149]</xref>.</p><p id="p0155">How the diversity and composition of fungal and bacterial species that constitute our microbiome effect human health is just beginning to be understood. Metabolomics and metagenomics of our human microbiome will help us map out microbial interaction networks <xref rid="b0750" ref-type="bibr">[150]</xref>, <xref rid="b0755" ref-type="bibr">[151]</xref>, and lead to identification of species or metabolites that can be used to control fungal infections <xref rid="b0760" ref-type="bibr">[152]</xref>, <xref rid="b0765" ref-type="bibr">[153]</xref>.</p></sec></sec><sec id="s0030"><label>2</label><title>Summary and outlook</title><p id="p0160">The high morbidity due to drug-resistant fungal species and strains underscores the need to develop new antifungal agents. Drugs like AmB and nystatin that were discovered from bacteria decades ago, and continue to be used in clinical practice, still motivate natural product discovery to look towards bacteria as sources of novel antifungals. Some bacterial clades, like Actinobacteria, have been studied extensively as sources of antifungals, but other clades with immense biosynthetic potential, like Myxobacteria, remain largely unexplored (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). We have to intensify our searches among novel bacteria from ecological niches where antifungal molecules are likely to confer a fitness advantage. Additionally, antifungals are just one of the many molecular mediators that manipulate diverse cellular process in fungi. For example, molecules that target fungal stress responses can be used in combination therapy to suppress the evolution of drug resistance. With a deeper understanding of the multitude of bacteria-fungi interactions, we may also discover molecules or species that specifically suppress fungal virulence.</p></sec><sec id="s0035"><title>CRediT authorship contribution statement</title><p id="p0165"><bold>Raghav Vij:</bold> Conceptualization, Software, Writing - original draft, Visualization. <bold>Bernhard Hube:</bold> Conceptualization, Writing - review &#x00026; editing, Supervision, Funding acquisition. <bold>Sascha Brunke:</bold> Conceptualization, Writing - review &#x00026; editing, Supervision, Funding acquisition.</p></sec><sec sec-type="COI-statement"><title>Declaration of Competing Interest</title><p id="p0170">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></sec></body><back><ref-list id="bi005"><title>References</title><ref id="b0005"><label>1</label><element-citation publication-type="journal" id="h0005"><person-group person-group-type="author"><name><surname>K&#x000f6;hler</surname><given-names>J.R.</given-names></name><name><surname>Casadevall</surname><given-names>A.</given-names></name><name><surname>Perfect</surname><given-names>J.</given-names></name></person-group><article-title>The spectrum of fungi that infects humans</article-title><source>Cold Spring Harb Perspect Med</source><volume>5</volume><year>2015</year><pub-id pub-id-type="doi">10.1101/cshperspect.a019273</pub-id></element-citation></ref><ref id="b0010"><label>2</label><element-citation publication-type="journal" id="h0010"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>M.A.</given-names></name><name><surname>Diekema</surname><given-names>D.J.</given-names></name><name><surname>Turnidge</surname><given-names>J.D.</given-names></name><name><surname>Castanheira</surname><given-names>M.</given-names></name><name><surname>Jones</surname><given-names>R.N.</given-names></name></person-group><article-title>Twenty years of the SENTRY Antifungal Surveillance Program: results for Candida species from 1997&#x02013;2016</article-title><source>Open Forum Infect Dis</source><volume>6</volume><year>2019</year><fpage>S79</fpage><lpage>S94</lpage><pub-id pub-id-type="doi">10.1093/ofid/ofy358</pub-id><pub-id pub-id-type="pmid">30895218</pub-id></element-citation></ref><ref id="b0015"><label>3</label><element-citation publication-type="journal" id="h0015"><person-group person-group-type="author"><name><surname>Lionakis</surname><given-names>M.S.</given-names></name><name><surname>Hohl</surname><given-names>T.M.</given-names></name></person-group><article-title>Call to action: how to tackle eCmerging nosocomial fungal infections</article-title><source>Cell Host Microbe</source><volume>27</volume><year>2020</year><fpage>859</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2020.04.011</pub-id><pub-id pub-id-type="pmid">32526182</pub-id></element-citation></ref><ref id="b0020"><label>4</label><element-citation publication-type="journal" id="h0020"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>M.C.</given-names></name><name><surname>Gurr</surname><given-names>S.J.</given-names></name><name><surname>Cuomo</surname><given-names>C.A.</given-names></name><name><surname>Blehert</surname><given-names>D.S.</given-names></name><name><surname>Jin</surname><given-names>H.</given-names></name><name><surname>Stukenbrock</surname><given-names>E.H.</given-names></name></person-group><source>MBio</source><volume>11</volume><year>2020</year><pub-id pub-id-type="doi">10.1128/mBio.00449-20</pub-id></element-citation></ref><ref id="b0025"><label>5</label><element-citation publication-type="journal" id="h0025"><person-group person-group-type="author"><name><surname>Lockhart</surname><given-names>S.R.</given-names></name><name><surname>Etienne</surname><given-names>K.A.</given-names></name><name><surname>Vallabhaneni</surname><given-names>S.</given-names></name><name><surname>Farooqi</surname><given-names>J.</given-names></name><name><surname>Chowdhary</surname><given-names>A.</given-names></name><name><surname>Govender</surname><given-names>N.P.</given-names></name></person-group><article-title>Simultaneous emergence of multidrug-resistant <italic>Candida auris</italic> on 3 continents confirmed by whole-genome sequencing and epidemiological analyses</article-title><source>Clin Infect Dis</source><volume>64</volume><year>2017</year><fpage>134</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/cid/ciw691</pub-id><pub-id pub-id-type="pmid">27988485</pub-id></element-citation></ref><ref id="b0030"><label>6</label><element-citation publication-type="journal" id="h0030"><person-group person-group-type="author"><name><surname>Seidel</surname><given-names>D.</given-names></name><name><surname>Mei&#x000df;ner</surname><given-names>A.</given-names></name><name><surname>Lackner</surname><given-names>M.</given-names></name><name><surname>Piepenbrock</surname><given-names>E.</given-names></name><name><surname>Salmanton-Garc&#x000ed;a</surname><given-names>J.</given-names></name><name><surname>Stecher</surname><given-names>M.</given-names></name></person-group><article-title>Prognostic factors in 264 adults with invasive <italic>Scedosporium spp.</italic> and <italic>Lomentospora prolificans</italic> infection reported in the literature and FungiScope&#x000ae;</article-title><source>Crit Rev Microbiol</source><volume>45</volume><year>2019</year><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1080/1040841X.2018.1514366</pub-id><pub-id pub-id-type="pmid">30628529</pub-id></element-citation></ref><ref id="b0035"><label>7</label><element-citation publication-type="journal" id="h0035"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>P.A.</given-names></name><name><surname>McNicholas</surname><given-names>P.M.</given-names></name><name><surname>Chau</surname><given-names>A.S.</given-names></name><name><surname>Patel</surname><given-names>R.</given-names></name><name><surname>Mendrick</surname><given-names>C.</given-names></name><name><surname>Ullmann</surname><given-names>A.J.</given-names></name></person-group><article-title>Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species</article-title><source>Antimicrob Agents Chemother</source><volume>53</volume><year>2009</year><fpage>5026</fpage><lpage>5034</lpage><pub-id pub-id-type="doi">10.1128/AAC.01031-09</pub-id><pub-id pub-id-type="pmid">19786600</pub-id></element-citation></ref><ref id="b0040"><label>8</label><mixed-citation publication-type="other" id="h0040">Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science (80-) 2018;360:739&#x02013;42. https://doi.org/10.1126/science.aap7999.</mixed-citation></ref><ref id="b0045"><label>9</label><element-citation publication-type="journal" id="h0045"><person-group person-group-type="author"><name><surname>Perfect</surname><given-names>J.R.</given-names></name></person-group><article-title>The antifungal pipeline: a reality check</article-title><source>Nat Rev Drug Discov</source><volume>16</volume><year>2017</year><fpage>603</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1038/nrd.2017.46</pub-id><pub-id pub-id-type="pmid">28496146</pub-id></element-citation></ref><ref id="b0050"><label>10</label><element-citation publication-type="journal" id="h0050"><person-group person-group-type="author"><name><surname>Wainwright</surname><given-names>M.</given-names></name></person-group><article-title>Moulds in folk medicine</article-title><source>Folklore</source><volume>100</volume><year>1989</year><fpage>162</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1080/0015587X.1989.9715763</pub-id></element-citation></ref><ref id="b0055"><label>11</label><element-citation publication-type="journal" id="h0055"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>K.</given-names></name></person-group><article-title>Antibiotics: from prehistory to the present day</article-title><source>J Antimicrob Chemother</source><volume>71</volume><year>2016</year><fpage>572</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1093/jac/dkv484</pub-id><pub-id pub-id-type="pmid">26851273</pub-id></element-citation></ref><ref id="b0060"><label>12</label><mixed-citation publication-type="other" id="h0060">Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. 1929. Bull World Health Organ 2001;79:780&#x02013;90. https://doi.org/10.1590/S0042-96862001000800017.</mixed-citation></ref><ref id="b0065"><label>13</label><element-citation publication-type="journal" id="h0065"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Natural products as sources of new drugs from 1981 to 2014</article-title><source>J Nat Prod</source><volume>79</volume><year>2016</year><fpage>629</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b01055</pub-id><pub-id pub-id-type="pmid">26852623</pub-id></element-citation></ref><ref id="b0070"><label>14</label><element-citation publication-type="journal" id="h0070"><person-group person-group-type="author"><name><surname>Aldholmi</surname><given-names>M.</given-names></name><name><surname>Marchand</surname><given-names>P.</given-names></name><name><surname>Ourliac-Garnier</surname><given-names>I.</given-names></name><name><surname>Le Pape</surname><given-names>P.</given-names></name><name><surname>Ganesan</surname><given-names>A.</given-names></name></person-group><article-title>A decade of antifungal leads from natural products: 2010&#x02013;2019</article-title><source>Pharmaceuticals</source><volume>12</volume><year>2019</year><fpage>182</fpage><pub-id pub-id-type="doi">10.3390/ph12040182</pub-id></element-citation></ref><ref id="b0075"><label>15</label><mixed-citation publication-type="other" id="h0075">Notable women in the physical sciences: a biographical dictionary. Choice Rev Online 1997;35:35-1273-35&#x02013;1273. https://doi.org/10.5860/choice.35-1273.</mixed-citation></ref><ref id="b0080"><label>16</label><element-citation publication-type="journal" id="h0080"><person-group person-group-type="author"><name><surname>Hazen</surname><given-names>E.L.</given-names></name><name><surname>Brown</surname><given-names>R.</given-names></name></person-group><article-title>Two antifungal agents produced by a soil actinomycete</article-title><source>Science</source><volume>112</volume><year>1950</year><fpage>423</fpage></element-citation></ref><ref id="b0085"><label>17</label><element-citation publication-type="journal" id="h0085"><person-group person-group-type="author"><name><surname>Donovick</surname><given-names>R.</given-names></name><name><surname>Gold</surname><given-names>W.</given-names></name><name><surname>Pagano</surname><given-names>J.F.</given-names></name><name><surname>Stout</surname><given-names>H.A.</given-names></name></person-group><article-title>Amphotericins A and B, antifungal antibiotics produced by a streptomycete I. In vitro studies</article-title><source>Antibiot Annu</source><volume>3</volume><year>1955</year><fpage>579</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">13355330</pub-id></element-citation></ref><ref id="b0090"><label>18</label><element-citation publication-type="journal" id="h0090"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>K.C.</given-names></name><name><surname>Dennis</surname><given-names>E.K.</given-names></name><name><surname>Watt</surname><given-names>D.S.</given-names></name><name><surname>Garneau-Tsodikova</surname><given-names>S.</given-names></name></person-group><article-title>A comprehensive overview of the medicinal chemistry of antifungal drugs: Perspectives and promise</article-title><source>Chem Soc Rev</source><volume>49</volume><year>2020</year><fpage>2426</fpage><lpage>2480</lpage><pub-id pub-id-type="doi">10.1039/c9cs00556k</pub-id><pub-id pub-id-type="pmid">32140691</pub-id></element-citation></ref><ref id="b0095"><label>19</label><mixed-citation publication-type="other" id="h0095">Rauseo AM, Coler-Reilly A, Larson L, Spec A. Hope on the horizon: Novel fungal treatments in development. Open Forum Infect Dis 2020;7. https://doi.org/10.1093/ofid/ofaa016.</mixed-citation></ref><ref id="b0100"><label>20</label><element-citation publication-type="journal" id="h0100"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Perez</surname><given-names>W.B.</given-names></name><name><surname>Jim&#x000e9;nez-Ortigosa</surname><given-names>C.</given-names></name><name><surname>Hough</surname><given-names>G.</given-names></name><name><surname>Locke</surname><given-names>J.B.</given-names></name><name><surname>Ong</surname><given-names>V.</given-names></name></person-group><article-title>CD101: a novel long-acting echinocandin</article-title><source>Cell Microbiol</source><volume>18</volume><year>2016</year><fpage>1308</fpage><lpage>1316</lpage><pub-id pub-id-type="doi">10.1111/cmi.12640</pub-id><pub-id pub-id-type="pmid">27354115</pub-id></element-citation></ref><ref id="b0105"><label>21</label><element-citation publication-type="journal" id="h0105"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez-Ortigosa</surname><given-names>C.</given-names></name><name><surname>Paderu</surname><given-names>P.</given-names></name><name><surname>Motyl</surname><given-names>M.R.</given-names></name><name><surname>Perlin</surname><given-names>D.S.</given-names></name></person-group><article-title>Enfumafungin derivative MK-3118 shows increased in vitro potency against clinical echinocandin-resistant candida species and aspergillus species isolates</article-title><source>Antimicrob Agents Chemother</source><volume>58</volume><year>2014</year><fpage>1248</fpage><lpage>1251</lpage><pub-id pub-id-type="doi">10.1128/AAC.02145-13</pub-id><pub-id pub-id-type="pmid">24323472</pub-id></element-citation></ref><ref id="b0110"><label>22</label><element-citation publication-type="journal" id="h0110"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>J.D.</given-names></name><name><surname>Sibley</surname><given-names>G.E.M.</given-names></name><name><surname>Beckmann</surname><given-names>N.</given-names></name><name><surname>Dobb</surname><given-names>K.S.</given-names></name><name><surname>Slater</surname><given-names>M.J.</given-names></name><name><surname>McEntee</surname><given-names>L.</given-names></name></person-group><article-title>F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase</article-title><source>Proc Natl Acad Sci U S A</source><volume>113</volume><year>2016</year><fpage>12809</fpage><lpage>12814</lpage><pub-id pub-id-type="doi">10.1073/pnas.1608304113</pub-id><pub-id pub-id-type="pmid">27791100</pub-id></element-citation></ref><ref id="b0115"><label>23</label><element-citation publication-type="journal" id="h0115"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>I.</given-names></name><name><surname>Yoshimura</surname><given-names>S.</given-names></name><name><surname>Masaki</surname><given-names>T.</given-names></name><name><surname>Takase</surname><given-names>S.</given-names></name><name><surname>Ohsumi</surname><given-names>K.</given-names></name><name><surname>Hashimoto</surname><given-names>M.</given-names></name></person-group><article-title>ASP2397: A novel antifungal agent produced by <italic>Acremonium persicinum</italic> MF-347833</article-title><source>J Antibiot (Tokyo)</source><volume>70</volume><year>2017</year><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1038/ja.2016.107</pub-id><pub-id pub-id-type="pmid">27599768</pub-id></element-citation></ref><ref id="b0120"><label>24</label><element-citation publication-type="journal" id="h0120"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>K.J.</given-names></name><name><surname>Ibrahim</surname><given-names>A.S.</given-names></name></person-group><article-title>Fosmanogepix: A review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections</article-title><source>J Fungi</source><volume>6</volume><year>2020</year><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.3390/jof6040239</pub-id></element-citation></ref><ref id="b0125"><label>25</label><element-citation publication-type="journal" id="h0125"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Sachs</surname><given-names>M.S.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name></person-group><article-title>The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections</article-title><source>Antimicrob Agents Chemother</source><volume>56</volume><year>2012</year><fpage>3758</fpage><lpage>3766</lpage><pub-id pub-id-type="doi">10.1128/AAC.00212-12</pub-id><pub-id pub-id-type="pmid">22508310</pub-id></element-citation></ref><ref id="b0130"><label>26</label><element-citation publication-type="journal" id="h0130"><person-group person-group-type="author"><name><surname>D&#x000e4;hn</surname><given-names>U.</given-names></name><name><surname>Hagenmaier</surname><given-names>H.</given-names></name><name><surname>H&#x000f6;hne</surname><given-names>H.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>W.A.</given-names></name><name><surname>Wolf</surname><given-names>G.</given-names></name><name><surname>Z&#x000e4;hner</surname><given-names>H.</given-names></name></person-group><article-title>Stoffwechselprodukte von mikroorganismen &#x02013; 154. Mitteilung. Nikkomycin, ein neuer Hemmstoff der Chitinsynthese bei Pilzen</article-title><source>Arch Microbiol</source><volume>107</volume><year>1976</year><fpage>143</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1007/BF00446834</pub-id><pub-id pub-id-type="pmid">1259515</pub-id></element-citation></ref><ref id="b0135"><label>27</label><element-citation publication-type="journal" id="h0135"><person-group person-group-type="author"><name><surname>Nix</surname><given-names>D.E.</given-names></name><name><surname>Swezey</surname><given-names>R.R.</given-names></name><name><surname>Hector</surname><given-names>R.</given-names></name><name><surname>Galgiani</surname><given-names>J.N.</given-names></name></person-group><article-title>Pharmacokinetics of nikkomycin Z after single rising oral doses</article-title><source>Antimicrob Agents Chemother</source><volume>53</volume><year>2009</year><fpage>2517</fpage><lpage>2521</lpage><pub-id pub-id-type="doi">10.1128/AAC.01609-08</pub-id><pub-id pub-id-type="pmid">19349517</pub-id></element-citation></ref><ref id="b0140"><label>28</label><mixed-citation publication-type="other" id="h0140">Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment - Full Text View - ClinicalTrials.gov n.d. https://clinicaltrials.gov/ct2/show/NCT00614666 (accessed June 22, 2020).</mixed-citation></ref><ref id="b0145"><label>29</label><element-citation publication-type="journal" id="h0145"><person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname><given-names>H.E.</given-names></name><name><surname>Parrent</surname><given-names>J.L.</given-names></name><name><surname>Jackson</surname><given-names>J.A.</given-names></name><name><surname>Moncalvo</surname><given-names>J.M.</given-names></name><name><surname>Vilgalys</surname><given-names>R.</given-names></name></person-group><article-title>Fungal community analysis by large-scale sequencing of environmental samples</article-title><source>Appl Environ Microbiol</source><volume>71</volume><year>2005</year><fpage>5544</fpage><lpage>5550</lpage><pub-id pub-id-type="doi">10.1128/AEM.71.9.5544-5550.2005</pub-id><pub-id pub-id-type="pmid">16151147</pub-id></element-citation></ref><ref id="b0150"><label>30</label><mixed-citation publication-type="other" id="h0150">Blackwell M. The fungi: 1, 2, 3 ... 5.1 million species? Am J Bot 2011;98:426&#x02013;38. https://doi.org/10.3732/ajb.1000298.</mixed-citation></ref><ref id="b0155"><label>31</label><element-citation publication-type="journal" id="h0155"><person-group person-group-type="author"><name><surname>Locey</surname><given-names>K.J.</given-names></name><name><surname>Lennon</surname><given-names>J.T.</given-names></name></person-group><article-title>Scaling laws predict global microbial diversity</article-title><source>Proc Natl Acad Sci U S A</source><volume>113</volume><year>2016</year><fpage>5970</fpage><lpage>5975</lpage><pub-id pub-id-type="doi">10.1073/pnas.1521291113</pub-id><pub-id pub-id-type="pmid">27140646</pub-id></element-citation></ref><ref id="b0160"><label>32</label><element-citation publication-type="journal" id="h0160"><person-group person-group-type="author"><name><surname>Willis</surname><given-names>A.</given-names></name></person-group><article-title>Extrapolating abundance curves has no predictive power for estimating microbial biodiversity</article-title><source>Proc Natl Acad Sci U S A</source><volume>113</volume><year>2016</year><fpage>E5096</fpage><pub-id pub-id-type="doi">10.1073/pnas.1608281113</pub-id><pub-id pub-id-type="pmid">27512033</pub-id></element-citation></ref><ref id="b0165"><label>33</label><element-citation publication-type="journal" id="h0165"><person-group person-group-type="author"><name><surname>Frey-Klett</surname><given-names>P.</given-names></name><name><surname>Burlinson</surname><given-names>P.</given-names></name><name><surname>Deveau</surname><given-names>A.</given-names></name><name><surname>Barret</surname><given-names>M.</given-names></name><name><surname>Tarkka</surname><given-names>M.</given-names></name><name><surname>Sarniguet</surname><given-names>A.</given-names></name></person-group><article-title>Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists</article-title><source>Microbiol Mol Biol Rev</source><volume>75</volume><year>2011</year><fpage>583</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1128/mmbr.00020-11</pub-id><pub-id pub-id-type="pmid">22126995</pub-id></element-citation></ref><ref id="b0170"><label>34</label><element-citation publication-type="journal" id="h0170"><person-group person-group-type="author"><name><surname>Scherlach</surname><given-names>K.</given-names></name><name><surname>Graupner</surname><given-names>K.</given-names></name><name><surname>Hertweck</surname><given-names>C.</given-names></name></person-group><article-title>Molecular bacterial-fungal interactions with impact on the environment, food and medicine</article-title><source>Annu Rev Microbiol</source><year>2013</year><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">24024632</pub-id></element-citation></ref><ref id="b0175"><label>35</label><element-citation publication-type="journal" id="h0175"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>D.Y.</given-names></name><name><surname>Crouch</surname><given-names>J.A.</given-names></name></person-group><article-title>Bacterial/Fungal interactions: from pathogens to mutualistic endosymbionts</article-title><source>Annu Rev Phytopathol</source><volume>47</volume><year>2009</year><fpage>63</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1146/annurev-phyto-080508-081729</pub-id><pub-id pub-id-type="pmid">19400650</pub-id></element-citation></ref><ref id="b0180"><label>36</label><element-citation publication-type="journal" id="h0180"><person-group person-group-type="author"><name><surname>Peleg</surname><given-names>A.Y.</given-names></name><name><surname>Hogan</surname><given-names>D.A.</given-names></name><name><surname>Mylonakis</surname><given-names>E.</given-names></name></person-group><article-title>Medically important bacterial-fungal interactions</article-title><source>Nat Rev Microbiol</source><volume>8</volume><year>2010</year><fpage>340</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2313</pub-id><pub-id pub-id-type="pmid">20348933</pub-id></element-citation></ref><ref id="b0185"><label>37</label><mixed-citation publication-type="other" id="h0185">Scherlach K, Hertweck C. Chemical Mediators at the Bacterial-Fungal Interface. Annu Rev Microbiol 2020;74:annurev-micro-012420-081224. https://doi.org/10.1146/annurev-micro-012420-081224.</mixed-citation></ref><ref id="b0190"><label>38</label><element-citation publication-type="journal" id="h0190"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>B.E.</given-names></name><name><surname>Phillips</surname><given-names>J.</given-names></name><name><surname>Miller</surname><given-names>K.</given-names></name><name><surname>Tandon</surname><given-names>A.</given-names></name><name><surname>Mav</surname><given-names>D.</given-names></name><name><surname>Shah</surname><given-names>M.R.</given-names></name></person-group><article-title>SWIFT-Review: A text-mining workbench for systematic review</article-title><source>Syst Rev</source><volume>5</volume><year>2016</year><fpage>87</fpage><pub-id pub-id-type="doi">10.1186/s13643-016-0263-z</pub-id><pub-id pub-id-type="pmid">27216467</pub-id></element-citation></ref><ref id="b0195"><label>39</label><mixed-citation publication-type="other" id="h0195">Denning DW, Bromley MJ. How to bolster the antifungal pipeline: Few drugs are coming to market, but opportunities for drug development exist. Science (80-) 2015;347:1414&#x02013;6. https://doi.org/10.1126/science.aaa6097.</mixed-citation></ref><ref id="b0200"><label>40</label><element-citation publication-type="journal" id="h0200"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>D.J.</given-names></name></person-group><article-title>rentrez: an R package for the NCBI eUtils API</article-title><source>R J</source><volume>9</volume><year>2017</year><fpage>520</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.32614/rj-2017-058</pub-id></element-citation></ref><ref id="b0205"><label>41</label><mixed-citation publication-type="other" id="h0205">Gr&#x000fc;nwald NJ, Foster ZSL, Chamberlain S. Taxa: An R package implementing data standards and methods for taxonomic data. F1000Research 2018;7:272. https://doi.org/10.12688/f1000research.14013.1.</mixed-citation></ref><ref id="b0210"><label>42</label><element-citation publication-type="journal" id="h0210"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>Z.S.L.</given-names></name><name><surname>Sharpton</surname><given-names>T.J.</given-names></name><name><surname>Gr&#x000fc;nwald</surname><given-names>N.J.</given-names></name></person-group><article-title>Metacoder: An R package for visualization and manipulation of community taxonomic diversity data</article-title><source>PLoS Comput Biol</source><volume>13</volume><year>2017</year><object-id pub-id-type="publisher-id">e1005404</object-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005404</pub-id></element-citation></ref><ref id="b0215"><label>43</label><element-citation publication-type="journal" id="h0215"><person-group person-group-type="author"><name><surname>Cimermancic</surname><given-names>P.</given-names></name><name><surname>Medema</surname><given-names>M.H.</given-names></name><name><surname>Claesen</surname><given-names>J.</given-names></name><name><surname>Kurita</surname><given-names>K.</given-names></name><name><surname>Wieland Brown</surname><given-names>L.C.</given-names></name><name><surname>Mavrommatis</surname><given-names>K.</given-names></name></person-group><article-title>Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters</article-title><source>Cell</source><volume>158</volume><year>2014</year><fpage>412</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.06.034</pub-id><pub-id pub-id-type="pmid">25036635</pub-id></element-citation></ref><ref id="b0220"><label>44</label><element-citation publication-type="journal" id="h0220"><person-group person-group-type="author"><name><surname>Stallfortha</surname><given-names>P.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Atlas for drug discovery</article-title><source>Proc Natl Acad Sci U S A</source><volume>111</volume><year>2014</year><fpage>3655</fpage><lpage>3656</lpage><pub-id pub-id-type="doi">10.1073/pnas.1400516111</pub-id><pub-id pub-id-type="pmid">24554079</pub-id></element-citation></ref><ref id="b0225"><label>45</label><element-citation publication-type="journal" id="h0225"><person-group person-group-type="author"><name><surname>Sharrar</surname><given-names>A.M.</given-names></name><name><surname>Crits-Christoph</surname><given-names>A.</given-names></name><name><surname>M&#x000e9;heust</surname><given-names>R.</given-names></name><name><surname>Diamond</surname><given-names>S.</given-names></name><name><surname>Starr</surname><given-names>E.P.</given-names></name><name><surname>Banfield</surname><given-names>J.F.</given-names></name></person-group><article-title>Bacterial secondary metabolite biosynthetic potential in soil varies with phylum, depth, and vegetation type</article-title><source>MBio</source><volume>11</volume><year>2020</year><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1128/MBIO.00416-20</pub-id></element-citation></ref><ref id="b0230"><label>46</label><element-citation publication-type="journal" id="h0230"><person-group person-group-type="author"><name><surname>Charlop-Powers</surname><given-names>Z.</given-names></name><name><surname>Owen</surname><given-names>J.G.</given-names></name><name><surname>Reddy</surname><given-names>B.V.B.</given-names></name><name><surname>Ternei</surname><given-names>M.A.</given-names></name><name><surname>Brady</surname><given-names>S.F.</given-names></name></person-group><article-title>Chemical-biogeographic survey of secondary metabolism in soil</article-title><source>Proc Natl Acad Sci U S A</source><volume>111</volume><year>2014</year><fpage>3757</fpage><lpage>3762</lpage><pub-id pub-id-type="doi">10.1073/pnas.1318021111</pub-id><pub-id pub-id-type="pmid">24550451</pub-id></element-citation></ref><ref id="b0235"><label>47</label><element-citation publication-type="journal" id="h0235"><person-group person-group-type="author"><name><surname>Charlop-Powers</surname><given-names>Z.</given-names></name><name><surname>Owen</surname><given-names>J.G.</given-names></name><name><surname>Reddy</surname><given-names>B.V.B.</given-names></name><name><surname>Ternei</surname><given-names>M.</given-names></name><name><surname>Guimaraes</surname><given-names>D.O.</given-names></name><name><surname>De Frias</surname><given-names>U.A.</given-names></name></person-group><article-title>Global biogeographic sampling of bacterial secondary metabolism</article-title><source>Elife</source><volume>2015</volume><year>2015</year><pub-id pub-id-type="doi">10.7554/eLife.05048</pub-id></element-citation></ref><ref id="b0240"><label>48</label><element-citation publication-type="journal" id="h0240"><person-group person-group-type="author"><name><surname>Doroghazi</surname><given-names>J.R.</given-names></name><name><surname>Metcalf</surname><given-names>W.W.</given-names></name></person-group><article-title>Comparative genomics of actinomycetes with a focus on natural product biosynthetic genes</article-title><source>BMC Genomics</source><volume>14</volume><year>2013</year><pub-id pub-id-type="doi">10.1186/1471-2164-14-611</pub-id></element-citation></ref><ref id="b0245"><label>49</label><element-citation publication-type="journal" id="h0245"><person-group person-group-type="author"><name><surname>Bibb</surname><given-names>M.J.</given-names></name></person-group><article-title>Regulation of secondary metabolism in streptomycetes</article-title><source>Curr Opin Microbiol</source><volume>8</volume><year>2005</year><fpage>208</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2005.02.016</pub-id><pub-id pub-id-type="pmid">15802254</pub-id></element-citation></ref><ref id="b0250"><label>50</label><element-citation publication-type="journal" id="h0250"><person-group person-group-type="author"><name><surname>Barka</surname><given-names>E.A.</given-names></name><name><surname>Vatsa</surname><given-names>P.</given-names></name><name><surname>Sanchez</surname><given-names>L.</given-names></name><name><surname>Gaveau-Vaillant</surname><given-names>N.</given-names></name><name><surname>Jacquard</surname><given-names>C.</given-names></name><name><surname>Klenk</surname><given-names>H.-P.</given-names></name></person-group><article-title>Taxonomy, physiology, and natural products of actinobacteria</article-title><source>Microbiol Mol Biol Rev</source><volume>80</volume><year>2016</year><fpage>1</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1128/mmbr.00019-15</pub-id><pub-id pub-id-type="pmid">26609051</pub-id></element-citation></ref><ref id="b0255"><label>51</label><element-citation publication-type="journal" id="h0255"><person-group person-group-type="author"><name><surname>Doroghazi</surname><given-names>J.R.</given-names></name><name><surname>Albright</surname><given-names>J.C.</given-names></name><name><surname>Goering</surname><given-names>A.W.</given-names></name><name><surname>Ju</surname><given-names>K.S.</given-names></name><name><surname>Haines</surname><given-names>R.R.</given-names></name><name><surname>Tchalukov</surname><given-names>K.A.</given-names></name></person-group><article-title>A roadmap for natural product discovery based on large-scale genomics and metabolomics</article-title><source>Nat Chem Biol</source><volume>10</volume><year>2014</year><fpage>963</fpage><lpage>968</lpage><pub-id pub-id-type="doi">10.1038/nCHeMBIO.1659</pub-id><pub-id pub-id-type="pmid">25262415</pub-id></element-citation></ref><ref id="b0260"><label>52</label><element-citation publication-type="journal" id="h0260"><person-group person-group-type="author"><name><surname>Velicer</surname><given-names>G.J.</given-names></name><name><surname>Vos</surname><given-names>M.</given-names></name></person-group><article-title>Sociobiology of the myxobacteria</article-title><source>Annu Rev Microbiol</source><volume>63</volume><year>2009</year><fpage>599</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.091208.073158</pub-id><pub-id pub-id-type="pmid">19575567</pub-id></element-citation></ref><ref id="b0265"><label>53</label><element-citation publication-type="journal" id="h0265"><person-group person-group-type="author"><name><surname>Velicer</surname><given-names>G.J.</given-names></name><name><surname>Mendes-soares</surname><given-names>H.</given-names></name><name><surname>Wielgoss</surname><given-names>S.</given-names></name></person-group><article-title>Whence comes social diversity? ecological and evolutionary analysis of the myxobacteria. Myxobact Genomics</article-title><source>Cell Mol Biol</source><volume>1</volume><year>2014</year><fpage>1</fpage><lpage>28</lpage></element-citation></ref><ref id="b0270"><label>54</label><element-citation publication-type="journal" id="h0270"><person-group person-group-type="author"><name><surname>Sch&#x000e4;berle</surname><given-names>T.F.</given-names></name><name><surname>Lohr</surname><given-names>F.</given-names></name><name><surname>Schmitz</surname><given-names>A.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name></person-group><article-title>Antibiotics from myxobacteria</article-title><source>Nat Prod Rep</source><volume>31</volume><year>2014</year><fpage>953</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1039/c4np00011k</pub-id><pub-id pub-id-type="pmid">24841474</pub-id></element-citation></ref><ref id="b0275"><label>55</label><element-citation publication-type="journal" id="h0275"><person-group person-group-type="author"><name><surname>Berleman</surname><given-names>J.E.</given-names></name><name><surname>Kirby</surname><given-names>J.R.</given-names></name></person-group><article-title>Deciphering the hunting strategy of a bacterial wolfpack</article-title><source>FEMS Microbiol Rev</source><volume>33</volume><year>2009</year><fpage>942</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.2009.00185.x</pub-id><pub-id pub-id-type="pmid">19519767</pub-id></element-citation></ref><ref id="b0280"><label>56</label><element-citation publication-type="journal" id="h0280"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>X.</given-names></name><name><surname>Ebright</surname><given-names>R.</given-names></name><name><surname>Wall</surname><given-names>D.</given-names></name></person-group><article-title>Antibiotic production by myxobacteria plays a role in predation</article-title><source>J Bacteriol</source><volume>193</volume><year>2011</year><fpage>4626</fpage><lpage>4633</lpage><pub-id pub-id-type="doi">10.1128/JB.05052-11</pub-id><pub-id pub-id-type="pmid">21764930</pub-id></element-citation></ref><ref id="b0285"><label>57</label><element-citation publication-type="journal" id="h0285"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>S.</given-names></name><name><surname>Kanbe</surname><given-names>S.</given-names></name><name><surname>Fudo</surname><given-names>R.</given-names></name></person-group><article-title>Lysis of basidiomycetous yeast, <italic>Rhodotorula glutinis</italic> caused by myxobacteria</article-title><source>J Gen Appl Microbiol</source><volume>39</volume><year>1993</year><fpage>419</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.2323/jgam.39.419</pub-id></element-citation></ref><ref id="b0290"><label>58</label><element-citation publication-type="journal" id="h0290"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Xia</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name></person-group><article-title>A novel outer membrane &#x003b2;-1,6-glucanase is deployed in the predation of fungi by myxobacteria</article-title><source>ISME J</source><volume>13</volume><year>2019</year><fpage>2223</fpage><lpage>2235</lpage><pub-id pub-id-type="doi">10.1038/s41396-019-0424-x</pub-id><pub-id pub-id-type="pmid">31065029</pub-id></element-citation></ref><ref id="b0295"><label>59</label><element-citation publication-type="journal" id="h0295"><person-group person-group-type="author"><name><surname>Livingstone</surname><given-names>P.G.</given-names></name><name><surname>Morphew</surname><given-names>R.M.</given-names></name><name><surname>Whitworth</surname><given-names>D.E.</given-names></name></person-group><article-title>Myxobacteria are able to prey broadly upon clinically-relevant pathogens, exhibiting a prey range which cannot be explained by phylogeny</article-title><source>Front Microbiol</source><volume>8</volume><year>2017</year><fpage>1593</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.01593</pub-id><pub-id pub-id-type="pmid">28878752</pub-id></element-citation></ref><ref id="b0300"><label>60</label><element-citation publication-type="journal" id="h0300"><person-group person-group-type="author"><name><surname>Ringel</surname><given-names>S.M.</given-names></name><name><surname>Greenough</surname><given-names>R.C.</given-names></name><name><surname>Roemer</surname><given-names>S.</given-names></name><name><surname>Connor</surname><given-names>D.</given-names></name><name><surname>Gutt</surname><given-names>A.L.</given-names></name><name><surname>Blair</surname><given-names>B.</given-names></name></person-group><article-title>Ambruticin* (W7783), A New Antifungal Antibiotic</article-title><source>J Antibiot (Tokyo)</source><volume>30</volume><year>1977</year><fpage>371</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.30.371</pub-id><pub-id pub-id-type="pmid">407203</pub-id></element-citation></ref><ref id="b0305"><label>61</label><element-citation publication-type="journal" id="h0305"><person-group person-group-type="author"><name><surname>Zirkle</surname><given-names>R.</given-names></name><name><surname>Ligon</surname><given-names>J.M.</given-names></name><name><surname>Moln&#x000e1;r</surname><given-names>I.</given-names></name></person-group><article-title>Heterologous production of the antifugal polyketide antibiotic soraphen A of <italic>Sorangium cellulosum</italic> So ce26 in <italic>Streptomyces lividans</italic></article-title><source>Microbiology</source><volume>150</volume><year>2004</year><fpage>2761</fpage><lpage>2774</lpage><pub-id pub-id-type="doi">10.1099/mic.0.27138-0</pub-id><pub-id pub-id-type="pmid">15289572</pub-id></element-citation></ref><ref id="b0310"><label>62</label><element-citation publication-type="journal" id="h0310"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>T.</given-names></name><name><surname>Krug</surname><given-names>D.</given-names></name><name><surname>Bozkurt</surname><given-names>N.</given-names></name><name><surname>Duddela</surname><given-names>S.</given-names></name><name><surname>Jansen</surname><given-names>R.</given-names></name><name><surname>Garcia</surname><given-names>R.</given-names></name></person-group><article-title>Correlating chemical diversity with taxonomic distance for discovery of natural products in myxobacteria</article-title><source>Nat Commun</source><volume>9</volume><year>2018</year><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/s41467-018-03184-1</pub-id><pub-id pub-id-type="pmid">29317637</pub-id></element-citation></ref><ref id="b0315"><label>63</label><element-citation publication-type="journal" id="h0315"><person-group person-group-type="author"><name><surname>Pye</surname><given-names>C.R.</given-names></name><name><surname>Bertin</surname><given-names>M.J.</given-names></name><name><surname>Lokey</surname><given-names>R.S.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name><name><surname>Linington</surname><given-names>R.G.</given-names></name></person-group><article-title>Retrospective analysis of natural products provides insights for future discovery trends</article-title><source>Proc Natl Acad Sci U S A</source><volume>114</volume><year>2017</year><fpage>5601</fpage><lpage>5606</lpage><pub-id pub-id-type="doi">10.1073/pnas.1614680114</pub-id><pub-id pub-id-type="pmid">28461474</pub-id></element-citation></ref><ref id="b0320"><label>64</label><element-citation publication-type="journal" id="h0320"><person-group person-group-type="author"><name><surname>Jannasch</surname><given-names>H.W.</given-names></name><name><surname>Jones</surname><given-names>G.E.</given-names></name></person-group><article-title>Bacterial populations in sea water as determined by different methods of enumeration</article-title><source>Limnol Oceanogr</source><volume>4</volume><year>1959</year><fpage>128</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.4319/lo.1959.4.2.0128</pub-id></element-citation></ref><ref id="b0325"><label>65</label><element-citation publication-type="journal" id="h0325"><person-group person-group-type="author"><name><surname>Staley</surname><given-names>J.T.</given-names></name><name><surname>Konopka</surname><given-names>A.</given-names></name></person-group><article-title>Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats</article-title><source>Annu Rev Microbiol</source><volume>39</volume><year>1985</year><fpage>321</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1146/annurev.mi.39.100185.001541</pub-id><pub-id pub-id-type="pmid">3904603</pub-id></element-citation></ref><ref id="b0330"><label>66</label><element-citation publication-type="journal" id="h0330"><person-group person-group-type="author"><name><surname>Connon</surname><given-names>S.A.</given-names></name><name><surname>Giovannoni</surname><given-names>S.J.</given-names></name></person-group><article-title>High-throughput methods for culturing microorganisms in very-low-nutrient media yield diverse new marine isolates</article-title><source>Appl Environ Microbiol</source><volume>68</volume><year>2002</year><fpage>3878</fpage><lpage>3885</lpage><pub-id pub-id-type="doi">10.1128/AEM.68.8.3878-3885.2002</pub-id><pub-id pub-id-type="pmid">12147485</pub-id></element-citation></ref><ref id="b0335"><label>67</label><element-citation publication-type="journal" id="h0335"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>B.C.</given-names></name><name><surname>Winsley</surname><given-names>T.</given-names></name><name><surname>Gillings</surname><given-names>M.</given-names></name><name><surname>Binnerup</surname><given-names>S.</given-names></name></person-group><article-title>Cultivating previously uncultured soil bacteria using a soil substrate membrane system</article-title><source>Nat Protoc</source><volume>3</volume><year>2008</year><fpage>1261</fpage><lpage>1269</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.102</pub-id><pub-id pub-id-type="pmid">18714294</pub-id></element-citation></ref><ref id="b0340"><label>68</label><element-citation publication-type="journal" id="h0340"><person-group person-group-type="author"><name><surname>Janssen</surname><given-names>P.H.</given-names></name><name><surname>Yates</surname><given-names>P.S.</given-names></name><name><surname>Grinton</surname><given-names>B.E.</given-names></name><name><surname>Taylor</surname><given-names>P.M.</given-names></name><name><surname>Sait</surname><given-names>M.</given-names></name></person-group><article-title>Improved culturability of soil bacteria and isolation in pure culture of novel members of the divisions Acidobacteria, Actinobacteria, Proteobacteria, and Verrucomicrobia</article-title><source>Appl Environ Microbiol</source><volume>68</volume><year>2002</year><fpage>2391</fpage><lpage>2396</lpage><pub-id pub-id-type="doi">10.1128/AEM.68.5.2391-2396.2002</pub-id><pub-id pub-id-type="pmid">11976113</pub-id></element-citation></ref><ref id="b0345"><label>69</label><mixed-citation publication-type="other" id="h0345">Kaeberlein T, Lewis K, Epstein SS. Isolating &#x0201c;uncultivable&#x0201d; microorganisms in pure culture in a simulated natural environment. Science (80-) 2002;296:1127&#x02013;9. https://doi.org/10.1126/science.1070633.</mixed-citation></ref><ref id="b0350"><label>70</label><element-citation publication-type="journal" id="h0350"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>E.J.</given-names></name></person-group><article-title>Growing unculturable bacteria</article-title><source>J Bacteriol</source><volume>194</volume><year>2012</year><fpage>4151</fpage><lpage>4160</lpage><pub-id pub-id-type="doi">10.1128/JB.00345-12</pub-id><pub-id pub-id-type="pmid">22661685</pub-id></element-citation></ref><ref id="b0355"><label>71</label><element-citation publication-type="journal" id="h0355"><person-group person-group-type="author"><name><surname>Streit</surname><given-names>W.R.</given-names></name><name><surname>Schmitz</surname><given-names>R.A.</given-names></name></person-group><article-title>Metagenomics &#x02013; the key to the uncultured microbes</article-title><source>Curr Opin Microbiol</source><volume>7</volume><year>2004</year><fpage>492</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2004.08.002</pub-id><pub-id pub-id-type="pmid">15451504</pub-id></element-citation></ref><ref id="b0360"><label>72</label><element-citation publication-type="journal" id="h0360"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>J.</given-names></name><name><surname>Wenzel</surname><given-names>S.C.</given-names></name><name><surname>Perlova</surname><given-names>O.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Gross</surname><given-names>F.</given-names></name><name><surname>Tang</surname><given-names>Z.</given-names></name></person-group><article-title>Efficient transfer of two large secondary metabolite pathway gene clusters into heterologous hosts by transposition</article-title><source>Nucleic Acids Res</source><year>2008;36.</year><pub-id pub-id-type="doi">10.1093/nar/gkn499</pub-id></element-citation></ref><ref id="b0365"><label>73</label><element-citation publication-type="journal" id="h0365"><person-group person-group-type="author"><name><surname>Wenzel</surname><given-names>S.C.</given-names></name><name><surname>Gross</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Fu</surname><given-names>J.</given-names></name><name><surname>Stewart</surname><given-names>A.F.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name></person-group><article-title>Heterologous expression of a myxobacterial natural products assembly line in pseudomonads via Red/ET recombineering</article-title><source>Chem Biol</source><volume>12</volume><year>2005</year><fpage>349</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2004.12.012</pub-id><pub-id pub-id-type="pmid">15797219</pub-id></element-citation></ref><ref id="b0370"><label>74</label><element-citation publication-type="journal" id="h0370"><person-group person-group-type="author"><name><surname>Brinkhoff</surname><given-names>T.</given-names></name><name><surname>Fischer</surname><given-names>D.</given-names></name><name><surname>Vollmers</surname><given-names>J.</given-names></name><name><surname>Voget</surname><given-names>S.</given-names></name><name><surname>Beardsley</surname><given-names>C.</given-names></name><name><surname>Thole</surname><given-names>S.</given-names></name></person-group><article-title>Biogeography and phylogenetic diversity of a cluster of exclusively marine myxobacteria</article-title><source>ISME J</source><volume>6</volume><year>2012</year><fpage>1260</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1038/ismej.2011.190</pub-id><pub-id pub-id-type="pmid">22189493</pub-id></element-citation></ref><ref id="b0375"><label>75</label><element-citation publication-type="journal" id="h0375"><person-group person-group-type="author"><name><surname>Komaki</surname><given-names>H.</given-names></name><name><surname>Fudou</surname><given-names>R.</given-names></name><name><surname>Iizuka</surname><given-names>T.</given-names></name><name><surname>Nakajima</surname><given-names>D.</given-names></name><name><surname>Okazaki</surname><given-names>K.</given-names></name><name><surname>Shibata</surname><given-names>D.</given-names></name></person-group><article-title>PCR detection of type I polyketide synthase genes in myxobacteria</article-title><source>Appl Environ Microbiol</source><volume>74</volume><year>2008</year><fpage>5571</fpage><lpage>5574</lpage><pub-id pub-id-type="doi">10.1128/AEM.00224-08</pub-id><pub-id pub-id-type="pmid">18606793</pub-id></element-citation></ref><ref id="b0380"><label>76</label><element-citation publication-type="journal" id="h0380"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>R.</given-names></name><name><surname>Gerth</surname><given-names>K.</given-names></name><name><surname>Stadler</surname><given-names>M.</given-names></name><name><surname>Dogma</surname><given-names>I.J.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name></person-group><article-title>Expanded phylogeny of myxobacteria and evidence for cultivation of the &#x0201c;unculturables&#x0201d;</article-title><source>Mol Phylogenet Evol</source><volume>57</volume><year>2010</year><fpage>878</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1016/j.ympev.2010.08.028</pub-id><pub-id pub-id-type="pmid">20807581</pub-id></element-citation></ref><ref id="b0385"><label>77</label><element-citation publication-type="journal" id="h0385"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Yao</surname><given-names>Q.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name></person-group><article-title>Meta-16S rRNA gene phylogenetic reconstruction reveals the astonishing diversity of cosmopolitan myxobacteria</article-title><source>Microorganisms</source><volume>7</volume><year>2019</year><fpage>551</fpage><pub-id pub-id-type="doi">10.3390/microorganisms7110551</pub-id></element-citation></ref><ref id="b0390"><label>78</label><element-citation publication-type="journal" id="h0390"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>R.</given-names></name><name><surname>La Clair</surname><given-names>J.J.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name></person-group><article-title>Future directions of marine myxobacterial natural product discovery inferred from metagenomics</article-title><source>Mar Drugs</source><volume>16</volume><year>2018</year><fpage>303</fpage><pub-id pub-id-type="doi">10.3390/md16090303</pub-id></element-citation></ref><ref id="b0395"><label>79</label><element-citation publication-type="journal" id="h0395"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name><name><surname>Wink</surname><given-names>J.</given-names></name></person-group><article-title>Future potential for anti-infectives from bacteria &#x02013; how to exploit biodiversity and genomic potential</article-title><source>Int J Med Microbiol</source><volume>304</volume><year>2014</year><fpage>3</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.ijmm.2013.09.004</pub-id><pub-id pub-id-type="pmid">24119567</pub-id></element-citation></ref><ref id="b0400"><label>80</label><element-citation publication-type="journal" id="h0400"><person-group person-group-type="author"><name><surname>Caffrey</surname><given-names>P.</given-names></name><name><surname>Lynch</surname><given-names>S.</given-names></name><name><surname>Flood</surname><given-names>E.</given-names></name><name><surname>Finnan</surname><given-names>S.</given-names></name><name><surname>Oliynyk</surname><given-names>M.</given-names></name></person-group><article-title>Erratum: Amphotericin biosynthesis in <italic>Streptomyces nodosus</italic>: Deductions from analysis of polyketide synthase and late genes (Chemistry and Biology 8(713&#x02013;723))</article-title><source>Chem Biol</source><volume>10</volume><year>2003</year><fpage>93</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(03)00007-3</pub-id></element-citation></ref><ref id="b0405"><label>81</label><element-citation publication-type="journal" id="h0405"><person-group person-group-type="author"><name><surname>Palacios</surname><given-names>D.S.</given-names></name><name><surname>Dailey</surname><given-names>I.</given-names></name><name><surname>Siebert</surname><given-names>D.M.</given-names></name><name><surname>Wilcock</surname><given-names>B.C.</given-names></name><name><surname>Burke</surname><given-names>M.D.</given-names></name></person-group><article-title>Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities</article-title><source>Proc Natl Acad Sci U S A</source><volume>108</volume><year>2011</year><fpage>6733</fpage><lpage>6738</lpage><pub-id pub-id-type="doi">10.1073/pnas.1015023108</pub-id><pub-id pub-id-type="pmid">21368185</pub-id></element-citation></ref><ref id="b0410"><label>82</label><element-citation publication-type="journal" id="h0410"><person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>P.</given-names></name><name><surname>Murphy</surname><given-names>C.D.</given-names></name><name><surname>Caffrey</surname><given-names>P.</given-names></name></person-group><article-title>Exploiting the genome sequence of <italic>Streptomyces nodosus</italic> for enhanced antibiotic production</article-title><source>Appl Microbiol Biotechnol</source><volume>100</volume><year>2016</year><fpage>1285</fpage><lpage>1295</lpage><pub-id pub-id-type="doi">10.1007/s00253-015-7060-9</pub-id><pub-id pub-id-type="pmid">26497174</pub-id></element-citation></ref><ref id="b0415"><label>83</label><element-citation publication-type="journal" id="h0415"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>K.C.</given-names></name><name><surname>Palacios</surname><given-names>D.S.</given-names></name><name><surname>Dailey</surname><given-names>I.</given-names></name><name><surname>Endo</surname><given-names>M.M.</given-names></name><name><surname>Uno</surname><given-names>B.E.</given-names></name><name><surname>Wilcock</surname><given-names>B.C.</given-names></name></person-group><article-title>Amphotericin primarily kills yeast by simply binding ergosterol</article-title><source>Proc Natl Acad Sci U S A</source><volume>109</volume><year>2012</year><fpage>2234</fpage><lpage>2239</lpage><pub-id pub-id-type="doi">10.1073/pnas.1117280109</pub-id><pub-id pub-id-type="pmid">22308411</pub-id></element-citation></ref><ref id="b0420"><label>84</label><element-citation publication-type="journal" id="h0420"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>T.M.</given-names></name><name><surname>Clay</surname><given-names>M.C.</given-names></name><name><surname>Cioffi</surname><given-names>A.G.</given-names></name><name><surname>Diaz</surname><given-names>K.A.</given-names></name><name><surname>Hisao</surname><given-names>G.S.</given-names></name><name><surname>Tuttle</surname><given-names>M.D.</given-names></name></person-group><article-title>Amphotericin forms an extramembranous and fungicidal sterol sponge</article-title><source>Nat Chem Biol</source><volume>10</volume><year>2014</year><fpage>400</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1496</pub-id><pub-id pub-id-type="pmid">24681535</pub-id></element-citation></ref><ref id="b0425"><label>85</label><element-citation publication-type="journal" id="h0425"><person-group person-group-type="author"><name><surname>Ermishkin</surname><given-names>L.N.</given-names></name><name><surname>Kasumov</surname><given-names>K.M.</given-names></name><name><surname>Potzeluyev</surname><given-names>V.M.</given-names></name></person-group><article-title>Single ionic channels induced in lipid bilayers by polyene antibiotics amphotericin B and nystatine</article-title><source>Nature</source><volume>262</volume><year>1976</year><fpage>698</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1038/262698a0</pub-id><pub-id pub-id-type="pmid">958440</pub-id></element-citation></ref><ref id="b0430"><label>86</label><element-citation publication-type="journal" id="h0430"><person-group person-group-type="author"><name><surname>Mesa-Arango</surname><given-names>A.C.</given-names></name><name><surname>Scorzoni</surname><given-names>L.</given-names></name><name><surname>Zaragoza</surname><given-names>O.</given-names></name></person-group><article-title>It only takes one to do many jobs: amphotericin B as antifungal and immunomodulatory drug</article-title><source>Front Microbiol</source><volume>3</volume><year>2012</year><pub-id pub-id-type="doi">10.3389/fmicb.2012.00286</pub-id></element-citation></ref><ref id="b0435"><label>87</label><element-citation publication-type="journal" id="h0435"><person-group person-group-type="author"><name><surname>Aszalos</surname><given-names>A.</given-names></name><name><surname>Bax</surname><given-names>A.</given-names></name><name><surname>Burlinson</surname><given-names>N.</given-names></name><name><surname>Roller</surname><given-names>P.</given-names></name><name><surname>Mcneal</surname><given-names>C.</given-names></name></person-group><article-title>Physico-chemical and microbiological comparison of nystatin, amphotericin A and amphotericin B, and structure of amphotericin A</article-title><source>J Antibiot (Tokyo)</source><volume>38</volume><year>1985</year><fpage>1699</fpage><lpage>1713</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.38.1699</pub-id><pub-id pub-id-type="pmid">3912360</pub-id></element-citation></ref><ref id="b0440"><label>88</label><element-citation publication-type="journal" id="h0440"><person-group person-group-type="author"><name><surname>Jenke-Kodama</surname><given-names>H.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name><name><surname>Dittmann</surname><given-names>E.</given-names></name></person-group><article-title>Evolutionary mechanisms underlying secondary metabolite diversity</article-title><source>Prog Drug Res</source><volume>65</volume><year>2008</year><fpage>120</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1007/978-3-7643-8117-2_3</pub-id></element-citation></ref><ref id="b0445"><label>89</label><element-citation publication-type="journal" id="h0445"><person-group person-group-type="author"><name><surname>Fischbach</surname><given-names>M.A.</given-names></name><name><surname>Walsh</surname><given-names>C.T.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>The evolution of gene collectives: how natural selection drives chemical innovation</article-title><source>Proc Natl Acad Sci U S A</source><volume>105</volume><year>2008</year><fpage>4601</fpage><lpage>4608</lpage><pub-id pub-id-type="doi">10.1073/pnas.0709132105</pub-id><pub-id pub-id-type="pmid">18216259</pub-id></element-citation></ref><ref id="b0450"><label>90</label><element-citation publication-type="journal" id="h0450"><person-group person-group-type="author"><name><surname>Medema</surname><given-names>M.H.</given-names></name><name><surname>Cimermancic</surname><given-names>P.</given-names></name><name><surname>Sali</surname><given-names>A.</given-names></name><name><surname>Takano</surname><given-names>E.</given-names></name><name><surname>Fischbach</surname><given-names>M.A.</given-names></name></person-group><article-title>A systematic computational analysis of biosynthetic gene cluster evolution: lessons for engineering biosynthesis</article-title><source>PLoS Comput Biol</source><volume>10</volume><year>2014</year><object-id pub-id-type="publisher-id">e1004016</object-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004016</pub-id></element-citation></ref><ref id="b0455"><label>91</label><element-citation publication-type="journal" id="h0455"><person-group person-group-type="author"><name><surname>Van Arnam</surname><given-names>E.B.</given-names></name><name><surname>Ruzzini</surname><given-names>A.C.</given-names></name><name><surname>Sit</surname><given-names>C.S.</given-names></name><name><surname>Horn</surname><given-names>H.</given-names></name><name><surname>Pinto-Tom&#x000e1;s</surname><given-names>A.A.</given-names></name><name><surname>Currie</surname><given-names>C.R.</given-names></name></person-group><article-title>Selvamicin, an atypical antifungal polyene from two alternative genomic contexts</article-title><source>Proc Natl Acad Sci U S A</source><volume>113</volume><year>2016</year><fpage>12940</fpage><lpage>12945</lpage><pub-id pub-id-type="doi">10.1073/pnas.1613285113</pub-id><pub-id pub-id-type="pmid">27803316</pub-id></element-citation></ref><ref id="b0460"><label>92</label><element-citation publication-type="journal" id="h0460"><person-group person-group-type="author"><name><surname>Aparicio</surname><given-names>J.F.</given-names></name><name><surname>Colina</surname><given-names>A.J.</given-names></name><name><surname>Ceballos</surname><given-names>E.</given-names></name><name><surname>Mart&#x000ed;n</surname><given-names>J.F.</given-names></name></person-group><article-title>The biosynthetic gene cluster for the 26-membered ring polyene macrolide pimaricin: a new polyketide synthase organization encoded by two subclusters separated by functionalization genes</article-title><source>J Biol Chem</source><volume>274</volume><year>1999</year><fpage>10133</fpage><lpage>10139</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.15.10133</pub-id><pub-id pub-id-type="pmid">10187796</pub-id></element-citation></ref><ref id="b0465"><label>93</label><element-citation publication-type="journal" id="h0465"><person-group person-group-type="author"><name><surname>Brautaset</surname><given-names>T.</given-names></name><name><surname>Sekurova</surname><given-names>O.N.</given-names></name><name><surname>Sletta</surname><given-names>H.</given-names></name><name><surname>Ellingsen</surname><given-names>T.E.</given-names></name><name><surname>Str&#x000f8;m</surname><given-names>A.R.</given-names></name><name><surname>Valla</surname><given-names>S.</given-names></name></person-group><article-title>Biosynthesis of the polyene antifungal antibiotic nystatin in <italic>Streptomyces noursei</italic> ATCC 11455: analysis of the gene cluster and deduction of the biosynthetic pathway</article-title><source>Chem Biol</source><volume>7</volume><year>2000</year><fpage>395</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(00)00120-4</pub-id><pub-id pub-id-type="pmid">10873841</pub-id></element-citation></ref><ref id="b0470"><label>94</label><element-citation publication-type="journal" id="h0470"><person-group person-group-type="author"><name><surname>Bentley</surname><given-names>S.D.</given-names></name><name><surname>Chater</surname><given-names>K.F.</given-names></name><name><surname>Cerde&#x000f1;o-T&#x000e1;rraga</surname><given-names>A.M.</given-names></name><name><surname>Challis</surname><given-names>G.L.</given-names></name><name><surname>Thomson</surname><given-names>N.R.</given-names></name><name><surname>James</surname><given-names>K.D.</given-names></name></person-group><article-title>Complete genome sequence of the model actinomycete <italic>Streptomyces coelicolor</italic> A3(2)</article-title><source>Nature</source><volume>417</volume><year>2002</year><fpage>141</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1038/417141a</pub-id><pub-id pub-id-type="pmid">12000953</pub-id></element-citation></ref><ref id="b0475"><label>95</label><element-citation publication-type="journal" id="h0475"><person-group person-group-type="author"><name><surname>Ziemert</surname><given-names>N.</given-names></name><name><surname>Alanjary</surname><given-names>M.</given-names></name><name><surname>Weber</surname><given-names>T.</given-names></name></person-group><article-title>The evolution of genome mining in microbes-a review</article-title><source>Nat Prod Rep</source><volume>33</volume><year>2016</year><fpage>988</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1039/c6np00025h</pub-id><pub-id pub-id-type="pmid">27272205</pub-id></element-citation></ref><ref id="b0480"><label>96</label><element-citation publication-type="journal" id="h0480"><person-group person-group-type="author"><name><surname>Crits-Christoph</surname><given-names>A.</given-names></name><name><surname>Diamond</surname><given-names>S.</given-names></name><name><surname>Butterfield</surname><given-names>C.N.</given-names></name><name><surname>Thomas</surname><given-names>B.C.</given-names></name><name><surname>Banfield</surname><given-names>J.F.</given-names></name></person-group><article-title>Novel soil bacteria possess diverse genes for secondary metabolite biosynthesis</article-title><source>Nature</source><volume>558</volume><year>2018</year><fpage>440</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0207-y</pub-id><pub-id pub-id-type="pmid">29899444</pub-id></element-citation></ref><ref id="b0485"><label>97</label><element-citation publication-type="journal" id="h0485"><person-group person-group-type="author"><name><surname>Schroeckh</surname><given-names>V.</given-names></name><name><surname>Scherlach</surname><given-names>K.</given-names></name><name><surname>N&#x000fc;tzmann</surname><given-names>H.W.</given-names></name><name><surname>Shelest</surname><given-names>E.</given-names></name><name><surname>Schmidt-Heck</surname><given-names>W.</given-names></name><name><surname>Schuemann</surname><given-names>J.</given-names></name></person-group><article-title>Intimate bacterial-fungal interaction triggers biosynthesis of archetypal polyketides in <italic>Aspergillus nidulans</italic></article-title><source>Proc Natl Acad Sci U S A</source><volume>106</volume><year>2009</year><fpage>14558</fpage><lpage>14563</lpage><pub-id pub-id-type="doi">10.1073/pnas.0901870106</pub-id><pub-id pub-id-type="pmid">19666480</pub-id></element-citation></ref><ref id="b0490"><label>98</label><element-citation publication-type="journal" id="h0490"><person-group person-group-type="author"><name><surname>Lincoln</surname><given-names>S.P.</given-names></name><name><surname>Fermor</surname><given-names>T.R.</given-names></name><name><surname>Tindall</surname><given-names>B.J.</given-names></name></person-group><article-title><italic>Janthinobacterium agaricidamnosum</italic> sp. nov., a soft rot pathogen of <italic>Agaricus bisporus</italic></article-title><source>Int J Syst Bacteriol</source><volume>49</volume><year>1999</year><fpage>1577</fpage><lpage>1589</lpage><pub-id pub-id-type="doi">10.1099/00207713-49-4-1577</pub-id><pub-id pub-id-type="pmid">10555339</pub-id></element-citation></ref><ref id="b0495"><label>99</label><element-citation publication-type="journal" id="h0495"><person-group person-group-type="author"><name><surname>Graupner</surname><given-names>K.</given-names></name><name><surname>Scherlach</surname><given-names>K.</given-names></name><name><surname>Bretschneider</surname><given-names>T.</given-names></name><name><surname>Lackner</surname><given-names>G.</given-names></name><name><surname>Roth</surname><given-names>M.</given-names></name><name><surname>Gross</surname><given-names>H.</given-names></name></person-group><article-title>Imaging mass spectrometry and genome mining reveal highly antifungal virulence factor of mushroom soft rot pathogen</article-title><source>Angew Chemie &#x02013; Int Ed</source><volume>51</volume><year>2012</year><fpage>13173</fpage><lpage>13177</lpage><pub-id pub-id-type="doi">10.1002/anie.201206658</pub-id></element-citation></ref><ref id="b0500"><label>100</label><element-citation publication-type="journal" id="h0500"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>D.</given-names></name><name><surname>Gessner</surname><given-names>G.</given-names></name><name><surname>Fill</surname><given-names>T.P.</given-names></name><name><surname>Barnett</surname><given-names>R.</given-names></name><name><surname>Tron</surname><given-names>K.</given-names></name><name><surname>Dornblut</surname><given-names>K.</given-names></name></person-group><article-title>Disruption of membrane integrity by the bacterium-derived antifungal jagaricin</article-title><source>Antimicrob Agents Chemother</source><volume>63</volume><year>2019</year><pub-id pub-id-type="doi">10.1128/AAC.00707-19</pub-id></element-citation></ref><ref id="b0505"><label>101</label><mixed-citation publication-type="other" id="h0505">Currie CR, Poulsen M, Mendenhall J, Boomsma JJ, Billen J. Coevolved crypts and exocrine glands support mutualistic bacteria in fungus-growing ants. Science (80-) 2006;311:81&#x02013;3. https://doi.org/10.1126/science.1119744.</mixed-citation></ref><ref id="b0510"><label>102</label><element-citation publication-type="journal" id="h0510"><person-group person-group-type="author"><name><surname>Haeder</surname><given-names>S.</given-names></name><name><surname>Wirth</surname><given-names>R.</given-names></name><name><surname>Herz</surname><given-names>H.</given-names></name><name><surname>Spiteller</surname><given-names>D.</given-names></name></person-group><article-title>Candicidin-producing Streptomyces support leaf-cutting ants to protect their fungus garden against the pathogenic fungus Escovopsis</article-title><source>Proc Natl Acad Sci U S A</source><volume>106</volume><year>2009</year><fpage>4742</fpage><lpage>4746</lpage><pub-id pub-id-type="doi">10.1073/pnas.0812082106</pub-id><pub-id pub-id-type="pmid">19270078</pub-id></element-citation></ref><ref id="b0515"><label>103</label><element-citation publication-type="journal" id="h0515"><person-group person-group-type="author"><name><surname>Barke</surname><given-names>J.</given-names></name><name><surname>Seipke</surname><given-names>R.F.</given-names></name><name><surname>Gr&#x000fc;schow</surname><given-names>S.</given-names></name><name><surname>Heavens</surname><given-names>D.</given-names></name><name><surname>Drou</surname><given-names>N.</given-names></name><name><surname>Bibb</surname><given-names>M.J.</given-names></name></person-group><article-title>A mixed community of actinomycetes produce multiple antibiotics for the fungus farming ant <italic>Acromyrmex octospinosus</italic></article-title><source>BMC Biol</source><volume>8</volume><year>2010</year><fpage>109</fpage><pub-id pub-id-type="doi">10.1186/1741-7007-8-109</pub-id><pub-id pub-id-type="pmid">20796277</pub-id></element-citation></ref><ref id="b0520"><label>104</label><element-citation publication-type="journal" id="h0520"><person-group person-group-type="author"><name><surname>Varanda-Haifig</surname><given-names>S.S.</given-names></name><name><surname>Albarici</surname><given-names>T.R.</given-names></name><name><surname>Nunes</surname><given-names>P.H.</given-names></name><name><surname>Haifig</surname><given-names>I.</given-names></name><name><surname>Vieira</surname><given-names>P.C.</given-names></name><name><surname>Rodrigues</surname><given-names>A.</given-names></name></person-group><article-title>Nature of the interactions between hypocrealean fungi and the mutualistic fungus of leaf-cutter ants</article-title><source>Antonie van Leeuwenhoek, Int J Gen Mol Microbiol</source><volume>110</volume><year>2017</year><fpage>593</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1007/s10482-016-0826-y</pub-id></element-citation></ref><ref id="b0525"><label>105</label><element-citation publication-type="journal" id="h0525"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>D.C.</given-names></name><name><surname>Poulsen</surname><given-names>M.</given-names></name><name><surname>Currie</surname><given-names>C.R.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Dentigerumycin: a bacterial mediator of an ant-fungus symbiosis</article-title><source>Nat Chem Biol</source><volume>5</volume><year>2009</year><fpage>391</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1038/nchembio.159</pub-id><pub-id pub-id-type="pmid">19330011</pub-id></element-citation></ref><ref id="b0530"><label>106</label><element-citation publication-type="journal" id="h0530"><person-group person-group-type="author"><name><surname>Wagg</surname><given-names>C.</given-names></name><name><surname>Schlaeppi</surname><given-names>K.</given-names></name><name><surname>Banerjee</surname><given-names>S.</given-names></name><name><surname>Kuramae</surname><given-names>E.E.</given-names></name><name><surname>van der Heijden</surname><given-names>M.G.A.</given-names></name></person-group><article-title>Fungal-bacterial diversity and microbiome complexity predict ecosystem functioning</article-title><source>Nat Commun</source><volume>10</volume><year>2019</year><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/s41467-019-12798-y</pub-id><pub-id pub-id-type="pmid">30602773</pub-id></element-citation></ref><ref id="b0535"><label>107</label><element-citation publication-type="journal" id="h0535"><person-group person-group-type="author"><name><surname>Cernava</surname><given-names>T.</given-names></name><name><surname>Erlacher</surname><given-names>A.</given-names></name><name><surname>Aschenbrenner</surname><given-names>I.A.</given-names></name><name><surname>Krug</surname><given-names>L.</given-names></name><name><surname>Lassek</surname><given-names>C.</given-names></name><name><surname>Riedel</surname><given-names>K.</given-names></name></person-group><article-title>Deciphering functional diversification within the lichen microbiota by meta-omics</article-title><source>Microbiome</source><volume>5</volume><year>2017</year><fpage>82</fpage><pub-id pub-id-type="doi">10.1186/s40168-017-0303-5</pub-id><pub-id pub-id-type="pmid">28724401</pub-id></element-citation></ref><ref id="b0540"><label>108</label><element-citation publication-type="journal" id="h0540"><person-group person-group-type="author"><name><surname>Chevrette</surname><given-names>M.G.</given-names></name><name><surname>Carlson</surname><given-names>C.M.</given-names></name><name><surname>Ortega</surname><given-names>H.E.</given-names></name><name><surname>Thomas</surname><given-names>C.</given-names></name><name><surname>Ananiev</surname><given-names>G.E.</given-names></name><name><surname>Barns</surname><given-names>K.J.</given-names></name></person-group><article-title>The antimicrobial potential of Streptomyces from insect microbiomes</article-title><source>Nat Commun</source><volume>10</volume><year>2019</year><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/s41467-019-08438-0</pub-id><pub-id pub-id-type="pmid">30602773</pub-id></element-citation></ref><ref id="b0545"><label>109</label><mixed-citation publication-type="other" id="h0545">Zhang F, Zhao M, Braun DR, Ericksen SS, Piotrowski JS, Nelson J, et al. A marine microbiome antifungal targets urgent-threat drug-resistant fungi. Science (80-) 2020;370:974&#x02013;8. https://doi.org/10.1126/science.abd6919.</mixed-citation></ref><ref id="b0550"><label>110</label><element-citation publication-type="journal" id="h0550"><person-group person-group-type="author"><name><surname>Layeghifard</surname><given-names>M.</given-names></name><name><surname>Hwang</surname><given-names>D.M.</given-names></name><name><surname>Guttman</surname><given-names>D.S.</given-names></name></person-group><article-title>Disentangling interactions in the microbiome: a network perspective</article-title><source>Trends Microbiol</source><volume>25</volume><year>2017</year><fpage>217</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2016.11.008</pub-id><pub-id pub-id-type="pmid">27916383</pub-id></element-citation></ref><ref id="b0555"><label>111</label><element-citation publication-type="journal" id="h0555"><person-group person-group-type="author"><name><surname>Revie</surname><given-names>N.M.</given-names></name><name><surname>Iyer</surname><given-names>K.R.</given-names></name><name><surname>Robbins</surname><given-names>N.</given-names></name><name><surname>Cowen</surname><given-names>L.E.</given-names></name></person-group><article-title>Antifungal drug resistance: evolution, mechanisms and impact</article-title><source>Curr Opin Microbiol</source><volume>45</volume><year>2018</year><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2018.02.005</pub-id><pub-id pub-id-type="pmid">29547801</pub-id></element-citation></ref><ref id="b0560"><label>112</label><element-citation publication-type="journal" id="h0560"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>J.</given-names></name><name><surname>Krysan</surname><given-names>D.J.</given-names></name></person-group><article-title>Drug resistance and tolerance in fungi</article-title><source>Nat Rev Microbiol</source><volume>18</volume><year>2020</year><fpage>319</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1038/s41579-019-0322-2</pub-id><pub-id pub-id-type="pmid">32047294</pub-id></element-citation></ref><ref id="b0565"><label>113</label><element-citation publication-type="journal" id="h0565"><person-group person-group-type="author"><name><surname>Challis</surname><given-names>G.L.</given-names></name><name><surname>Hopwood</surname><given-names>D.A.</given-names></name></person-group><article-title>Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><year>2003</year><fpage>14555</fpage><lpage>14561</lpage><pub-id pub-id-type="doi">10.1073/pnas.1934677100</pub-id><pub-id pub-id-type="pmid">12970466</pub-id></element-citation></ref><ref id="b0570"><label>114</label><element-citation publication-type="journal" id="h0570"><person-group person-group-type="author"><name><surname>Firn</surname><given-names>R.D.</given-names></name><name><surname>Jones</surname><given-names>C.G.</given-names></name></person-group><article-title>The evolution of secondary metabolism &#x02013; a unifying model</article-title><source>Mol Microbiol</source><volume>37</volume><year>2000</year><fpage>989</fpage><lpage>994</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2000.02098.x</pub-id><pub-id pub-id-type="pmid">10972818</pub-id></element-citation></ref><ref id="b0575"><label>115</label><element-citation publication-type="journal" id="h0575"><person-group person-group-type="author"><name><surname>Hatanaka</surname><given-names>H.</given-names></name><name><surname>Iwami</surname><given-names>M.</given-names></name><name><surname>Kino</surname><given-names>T.</given-names></name><name><surname>Goto</surname><given-names>T.</given-names></name><name><surname>Okuhara</surname><given-names>M.</given-names></name></person-group><article-title>FR-900520 and FR-900523, novel immunosuppressants isolated from a streptomyces: I. Taxonomy of the producing strain</article-title><source>J Antibiot (Tokyo)</source><volume>41</volume><year>1988</year><fpage>1586</fpage><lpage>1591</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.41.1586</pub-id><pub-id pub-id-type="pmid">3198493</pub-id></element-citation></ref><ref id="b0580"><label>116</label><element-citation publication-type="journal" id="h0580"><person-group person-group-type="author"><name><surname>Deboer</surname><given-names>C.</given-names></name><name><surname>Meulman</surname><given-names>P.A.</given-names></name><name><surname>Wnuk</surname><given-names>R.J.</given-names></name><name><surname>Peterson</surname><given-names>D.H.</given-names></name></person-group><article-title>Geldanamycin, a new antibiotic</article-title><source>J Antibiot (Tokyo)</source><volume>23</volume><year>1970</year><fpage>442</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.23.442</pub-id><pub-id pub-id-type="pmid">5459626</pub-id></element-citation></ref><ref id="b0585"><label>117</label><element-citation publication-type="journal" id="h0585"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>J.P.</given-names></name><name><surname>Kim</surname><given-names>J.L.</given-names></name><name><surname>Kim</surname><given-names>E.E.</given-names></name><name><surname>Sintchak</surname><given-names>M.D.</given-names></name><name><surname>Thomson</surname><given-names>J.A.</given-names></name><name><surname>Fitzgibbon</surname><given-names>M.J.</given-names></name></person-group><article-title>X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex</article-title><source>Cell</source><volume>82</volume><year>1995</year><fpage>507</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90439-5</pub-id><pub-id pub-id-type="pmid">7543369</pub-id></element-citation></ref><ref id="b0590"><label>118</label><element-citation publication-type="journal" id="h0590"><person-group person-group-type="author"><name><surname>Steinbach</surname><given-names>W.J.</given-names></name><name><surname>Reedy</surname><given-names>J.L.</given-names></name><name><surname>Cramer</surname><given-names>R.A.</given-names></name><name><surname>Perfect</surname><given-names>J.R.</given-names></name><name><surname>Heitman</surname><given-names>J.</given-names></name></person-group><article-title>Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections</article-title><source>Nat Rev Microbiol</source><volume>5</volume><year>2007</year><fpage>418</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1680</pub-id><pub-id pub-id-type="pmid">17505522</pub-id></element-citation></ref><ref id="b0595"><label>119</label><element-citation publication-type="journal" id="h0595"><person-group person-group-type="author"><name><surname>Juvvadi</surname><given-names>P.R.</given-names></name><name><surname>Lee</surname><given-names>S.C.</given-names></name><name><surname>Heitman</surname><given-names>J.</given-names></name><name><surname>Steinbach</surname><given-names>W.J.</given-names></name></person-group><article-title>Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach</article-title><source>Virulence</source><volume>8</volume><year>2017</year><fpage>186</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1080/21505594.2016.1201250</pub-id><pub-id pub-id-type="pmid">27325145</pub-id></element-citation></ref><ref id="b0600"><label>120</label><element-citation publication-type="journal" id="h0600"><person-group person-group-type="author"><name><surname>Odom</surname><given-names>A.</given-names></name><name><surname>Del Poeta</surname><given-names>M.</given-names></name><name><surname>Perfect</surname><given-names>J.</given-names></name><name><surname>Heitman</surname><given-names>J.</given-names></name></person-group><article-title>The immunosuppressant FK506 and its nonimmunosuppressive analog L- 685,818 are toxic to <italic>Cryptococcus neoformans</italic> by inhibition of a common target protein</article-title><source>Antimicrob Agents Chemother</source><volume>41</volume><year>1997</year><fpage>156</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1128/aac.41.1.156</pub-id><pub-id pub-id-type="pmid">8980772</pub-id></element-citation></ref><ref id="b0605"><label>121</label><element-citation publication-type="journal" id="h0605"><person-group person-group-type="author"><name><surname>Begley</surname><given-names>D.W.</given-names></name><name><surname>Fox</surname><given-names>D.</given-names></name><name><surname>Jenner</surname><given-names>D.</given-names></name><name><surname>Juli</surname><given-names>C.</given-names></name><name><surname>Pierce</surname><given-names>P.G.</given-names></name><name><surname>Abendroth</surname><given-names>J.</given-names></name></person-group><article-title>A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins</article-title><source>Antimicrob Agents Chemother</source><volume>58</volume><year>2014</year><fpage>1458</fpage><lpage>1467</lpage><pub-id pub-id-type="doi">10.1128/AAC.01875-13</pub-id><pub-id pub-id-type="pmid">24366729</pub-id></element-citation></ref><ref id="b0610"><label>122</label><mixed-citation publication-type="other" id="h0610">Lee Y, Lee KT, Lee SJ, Beom JY, Hwangbo A, Jung JA, et al. In vitro and in vivo assessment of FK506 analogs as novel antifungal drug candidates. Antimicrob Agents Chemother 2018;62. https://doi.org/10.1128/AAC.01627-18.</mixed-citation></ref><ref id="b0615"><label>123</label><mixed-citation publication-type="other" id="h0615">LeBlanc E V., Polvi EJ, Veri AO, Priv&#x000e9; GG, Cowen LE. Structure-guided approaches to targeting stress responses in human fungal pathogens. J Biol Chem 2020;12:jbc.REV120.013731. https://doi.org/10.1074/jbc.rev120.013731.</mixed-citation></ref><ref id="b0620"><label>124</label><element-citation publication-type="journal" id="h0620"><person-group person-group-type="author"><name><surname>Schwecke</surname><given-names>T.</given-names></name><name><surname>Aparicio</surname><given-names>J.F.</given-names></name><name><surname>Moln&#x000e1;r</surname><given-names>I.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>A.</given-names></name><name><surname>Khaw</surname><given-names>L.E.</given-names></name><name><surname>Haydock</surname><given-names>S.F.</given-names></name></person-group><article-title>The biosynthetic gene cluster for the polyketide immunosuppressant rapamycin</article-title><source>Proc Natl Acad Sci U S A</source><volume>92</volume><year>1995</year><fpage>7839</fpage><lpage>7843</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.17.7839</pub-id><pub-id pub-id-type="pmid">7644502</pub-id></element-citation></ref><ref id="b0625"><label>125</label><element-citation publication-type="journal" id="h0625"><person-group person-group-type="author"><name><surname>Cowen</surname><given-names>L.E.</given-names></name></person-group><article-title>Hsp90 orchestrates stress response signaling governing fungal drug resistance</article-title><source>PLoS Pathog</source><volume>5</volume><year>2009</year><object-id pub-id-type="publisher-id">e1000471</object-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000471</pub-id></element-citation></ref><ref id="b0630"><label>126</label><mixed-citation publication-type="other" id="h0630">Cowen LE, Lindquist S. Cell biology: Hsp90 potentiates the rapid evolution of new traits: Drug resistance in diverse fungi. Science (80-) 2005;309:2185&#x02013;9. https://doi.org/10.1126/science.1118370.</mixed-citation></ref><ref id="b0635"><label>127</label><element-citation publication-type="journal" id="h0635"><person-group person-group-type="author"><name><surname>Cowen</surname><given-names>L.E.</given-names></name><name><surname>Singh</surname><given-names>S.D.</given-names></name><name><surname>K&#x000f6;hler</surname><given-names>J.R.</given-names></name><name><surname>Collins</surname><given-names>C.</given-names></name><name><surname>Zaas</surname><given-names>A.K.</given-names></name><name><surname>Schell</surname><given-names>W.A.</given-names></name></person-group><article-title>Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease</article-title><source>Proc Natl Acad Sci U S A</source><volume>106</volume><year>2009</year><fpage>2818</fpage><lpage>2823</lpage><pub-id pub-id-type="doi">10.1073/pnas.0813394106</pub-id><pub-id pub-id-type="pmid">19196973</pub-id></element-citation></ref><ref id="b0640"><label>128</label><element-citation publication-type="journal" id="h0640"><person-group person-group-type="author"><name><surname>Cowen</surname><given-names>L.E.</given-names></name><name><surname>Carpenter</surname><given-names>A.E.</given-names></name><name><surname>Matangkasombut</surname><given-names>O.</given-names></name><name><surname>Fink</surname><given-names>G.R.</given-names></name><name><surname>Lindquist</surname><given-names>S.</given-names></name></person-group><article-title>Genetic architecture of Hsp90-dependent drug resistance</article-title><source>Eukaryot Cell</source><volume>5</volume><year>2006</year><fpage>2184</fpage><lpage>2188</lpage><pub-id pub-id-type="doi">10.1128/EC.00274-06</pub-id><pub-id pub-id-type="pmid">17056742</pub-id></element-citation></ref><ref id="b0645"><label>129</label><element-citation publication-type="journal" id="h0645"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.N.</given-names></name><name><surname>Wang</surname><given-names>K.L.</given-names></name><name><surname>Wu</surname><given-names>Z.H.</given-names></name><name><surname>Tian</surname><given-names>R.M.</given-names></name><name><surname>Liu</surname><given-names>G.Z.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name></person-group><article-title>Biological and chemical diversity of bacteria associated with a marine flatworm</article-title><source>Mar Drugs</source><volume>15</volume><year>2017</year><pub-id pub-id-type="doi">10.3390/md15090281</pub-id></element-citation></ref><ref id="b0650"><label>130</label><element-citation publication-type="journal" id="h0650"><person-group person-group-type="author"><name><surname>Supong</surname><given-names>K.</given-names></name><name><surname>Sripreechasak</surname><given-names>P.</given-names></name><name><surname>Tanasupawat</surname><given-names>S.</given-names></name><name><surname>Danwisetkanjana</surname><given-names>K.</given-names></name><name><surname>Rachtawee</surname><given-names>P.</given-names></name><name><surname>Pittayakhajonwut</surname><given-names>P.</given-names></name></person-group><article-title>Investigation on antimicrobial agents of the terrestrial <italic>Streptomyces sp.</italic> BCC71188</article-title><source>Appl Microbiol Biotechnol</source><year>2017;101:533&#x02013;43.</year><pub-id pub-id-type="doi">10.1007/s00253-016-7804-1</pub-id></element-citation></ref><ref id="b0655"><label>131</label><element-citation publication-type="journal" id="h0655"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>M.L.</given-names></name><name><surname>Limon</surname><given-names>J.J.</given-names></name><name><surname>Bar</surname><given-names>A.S.</given-names></name><name><surname>Leal</surname><given-names>C.A.</given-names></name><name><surname>Gargus</surname><given-names>M.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name></person-group><article-title>Immunological consequences of intestinal fungal dysbiosis</article-title><source>Cell Host Microbe</source><volume>19</volume><year>2016</year><fpage>865</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.05.003</pub-id><pub-id pub-id-type="pmid">27237365</pub-id></element-citation></ref><ref id="b0660"><label>132</label><element-citation publication-type="journal" id="h0660"><person-group person-group-type="author"><name><surname>Iliev</surname><given-names>I.D.</given-names></name><name><surname>Leonardi</surname><given-names>I.</given-names></name></person-group><article-title>Fungal dysbiosis: Immunity and interactions at mucosal barriers</article-title><source>Nat Rev Immunol</source><volume>17</volume><year>2017</year><fpage>635</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.55</pub-id><pub-id pub-id-type="pmid">28604735</pub-id></element-citation></ref><ref id="b0665"><label>133</label><element-citation publication-type="journal" id="h0665"><person-group person-group-type="author"><name><surname>Brunke</surname><given-names>S.</given-names></name><name><surname>Mogavero</surname><given-names>S.</given-names></name><name><surname>Kasper</surname><given-names>L.</given-names></name><name><surname>Hube</surname><given-names>B.</given-names></name></person-group><article-title>Virulence factors in fungal pathogens of man</article-title><source>Curr Opin Microbiol</source><volume>32</volume><year>2016</year><fpage>89</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2016.05.010</pub-id><pub-id pub-id-type="pmid">27257746</pub-id></element-citation></ref><ref id="b0670"><label>134</label><element-citation publication-type="journal" id="h0670"><person-group person-group-type="author"><name><surname>Jacobsen</surname><given-names>I.D.</given-names></name><name><surname>Wilson</surname><given-names>D.</given-names></name><name><surname>W&#x000e4;chtler</surname><given-names>B.</given-names></name><name><surname>Brunke</surname><given-names>S.</given-names></name><name><surname>Naglik</surname><given-names>J.R.</given-names></name><name><surname>Hube</surname><given-names>B.</given-names></name></person-group><article-title><italic>Candida albicans</italic> dimorphism as a therapeutic target</article-title><source>Expert Rev Anti Infect Ther</source><volume>10</volume><year>2012</year><fpage>85</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1586/eri.11.152</pub-id><pub-id pub-id-type="pmid">22149617</pub-id></element-citation></ref><ref id="b0675"><label>135</label><element-citation publication-type="journal" id="h0675"><person-group person-group-type="author"><name><surname>Shareck</surname><given-names>J.</given-names></name><name><surname>Belhumeur</surname><given-names>P.</given-names></name></person-group><article-title>Modulation of morphogenesis in <italic>Candida albicans</italic> by various small molecules</article-title><source>Eukaryot Cell</source><volume>10</volume><year>2011</year><fpage>1004</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.1128/EC.05030-11</pub-id><pub-id pub-id-type="pmid">21642508</pub-id></element-citation></ref><ref id="b0680"><label>136</label><element-citation publication-type="journal" id="h0680"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>J.R.</given-names></name></person-group><article-title>Suppression of fungal growth exhibited by Pseudomonas aeruginosa</article-title><source>J Clin Microbiol</source><volume>32</volume><year>1994</year><fpage>525</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1128/jcm.32.2.525-527.1994</pub-id><pub-id pub-id-type="pmid">8150966</pub-id></element-citation></ref><ref id="b0685"><label>137</label><mixed-citation publication-type="other" id="h0685">Hogan DA, Kolter R. Pseudomonas-Candida interactions: An ecological role for virulence factors. Science (80-) 2002;296:2229&#x02013;32. https://doi.org/10.1126/science.1070784.</mixed-citation></ref><ref id="b0690"><label>138</label><element-citation publication-type="journal" id="h0690"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>D.A.</given-names></name><name><surname>Vik</surname><given-names>&#x000c5;.</given-names></name><name><surname>Kolter</surname><given-names>R.</given-names></name></person-group><article-title>A <italic>Pseudomonas aeruginosa</italic> quorum-sensing molecule influences <italic>Candida albicans</italic> morphology</article-title><source>Mol Microbiol</source><volume>54</volume><year>2004</year><fpage>1212</fpage><lpage>1223</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04349.x</pub-id><pub-id pub-id-type="pmid">15554963</pub-id></element-citation></ref><ref id="b0695"><label>139</label><element-citation publication-type="journal" id="h0695"><person-group person-group-type="author"><name><surname>Boon</surname><given-names>C.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.H.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>J.L.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name></person-group><article-title>A novel DSF-like signal from <italic>Burkholderia cenocepacia</italic> interferes with <italic>Candida albicans</italic> morphological transition</article-title><source>ISME J</source><volume>2</volume><year>2008</year><fpage>27</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1038/ismej.2007.76</pub-id><pub-id pub-id-type="pmid">18049456</pub-id></element-citation></ref><ref id="b0700"><label>140</label><element-citation publication-type="journal" id="h0700"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>C.E.</given-names></name><name><surname>Cruz</surname><given-names>M.R.</given-names></name><name><surname>Garsin</surname><given-names>D.A.</given-names></name><name><surname>Lorenz</surname><given-names>M.C.</given-names></name></person-group><article-title><italic>Enterococcus faecalis</italic> bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans</article-title><source>Proc Natl Acad Sci U S A</source><volume>114</volume><year>2017</year><fpage>4507</fpage><lpage>4512</lpage><pub-id pub-id-type="doi">10.1073/pnas.1620432114</pub-id><pub-id pub-id-type="pmid">28396417</pub-id></element-citation></ref><ref id="b0705"><label>141</label><element-citation publication-type="journal" id="h0705"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>J.</given-names></name><name><surname>El-Gendy</surname><given-names>A.O.</given-names></name><name><surname>Mansy</surname><given-names>M.S.</given-names></name><name><surname>Ramadan</surname><given-names>M.A.</given-names></name><name><surname>Aziz</surname><given-names>R.K.</given-names></name></person-group><article-title>The biosurfactants iturin, lichenysin and surfactin, from vaginally isolated lactobacilli, prevent biofilm formation by pathogenic Candida</article-title><source>FEMS Microbiol Lett</source><volume>367</volume><year>2020</year><fpage>126</fpage><pub-id pub-id-type="doi">10.1093/femsle/fnaa126</pub-id></element-citation></ref><ref id="b0710"><label>142</label><element-citation publication-type="journal" id="h0710"><person-group person-group-type="author"><name><surname>Zida</surname><given-names>A.</given-names></name><name><surname>Bamba</surname><given-names>S.</given-names></name><name><surname>Yacouba</surname><given-names>A.</given-names></name><name><surname>Ouedraogo-Traore</surname><given-names>R.</given-names></name><name><surname>Guiguemd&#x000e9;</surname><given-names>R.T.</given-names></name></person-group><article-title>Substances naturelles actives sur <italic>Candida albicans</italic>, sources de nouveaux m&#x000e9;dicaments antifongiques : revue de la litt&#x000e9;rature</article-title><source>J Mycol Med</source><volume>27</volume><year>2017</year><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.mycmed.2016.10.002</pub-id><pub-id pub-id-type="pmid">27842800</pub-id></element-citation></ref><ref id="b0715"><label>143</label><element-citation publication-type="journal" id="h0715"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>F.L.</given-names></name><name><surname>Kronstad</surname><given-names>J.</given-names></name></person-group><article-title>The spectrum of interactions between cryptococcus neoformans and bacteria</article-title><source>J Fungi</source><volume>5</volume><year>2019</year><fpage>31</fpage><pub-id pub-id-type="doi">10.3390/jof5020031</pub-id></element-citation></ref><ref id="b0720"><label>144</label><element-citation publication-type="journal" id="h0720"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>F.L.</given-names></name><name><surname>Kronstad</surname><given-names>J.W.</given-names></name></person-group><article-title>Disarming fungal pathogens: <italic>Bacillus safensis</italic> inhibits virulence factor production and biofilm formation by <italic>Cryptococcus neoformans</italic> and <italic>Candida albicans</italic></article-title><source>MBio</source><volume>8</volume><year>2017</year><pub-id pub-id-type="doi">10.1128/mBio.01537-17</pub-id></element-citation></ref><ref id="b0725"><label>145</label><element-citation publication-type="journal" id="h0725"><person-group person-group-type="author"><name><surname>Vu</surname><given-names>K.</given-names></name><name><surname>Garcia</surname><given-names>J.A.</given-names></name><name><surname>Gelli</surname><given-names>A.</given-names></name></person-group><article-title>Cryptococcal meningitis and antivirulence therapeutic strategies</article-title><source>Front Microbiol</source><volume>10</volume><year>2019</year><fpage>353</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.00353</pub-id><pub-id pub-id-type="pmid">30863389</pub-id></element-citation></ref><ref id="b0730"><label>146</label><element-citation publication-type="journal" id="h0730"><person-group person-group-type="author"><name><surname>Matsubara</surname><given-names>V.H.</given-names></name><name><surname>Bandara</surname><given-names>H.M.H.N.</given-names></name><name><surname>Mayer</surname><given-names>M.P.A.</given-names></name><name><surname>Samaranayake</surname><given-names>L.P.</given-names></name></person-group><article-title>Probiotics as antifungals in mucosal candidiasis</article-title><source>Clin Infect Dis</source><volume>62</volume><year>2016</year><fpage>1143</fpage><lpage>1153</lpage><pub-id pub-id-type="doi">10.1093/cid/ciw038</pub-id><pub-id pub-id-type="pmid">26826375</pub-id></element-citation></ref><ref id="b0735"><label>147</label><element-citation publication-type="journal" id="h0735"><person-group person-group-type="author"><name><surname>James</surname><given-names>K.M.</given-names></name><name><surname>MacDonald</surname><given-names>K.W.</given-names></name><name><surname>Chanyi</surname><given-names>R.M.</given-names></name><name><surname>Cadieux</surname><given-names>P.A.</given-names></name><name><surname>Burton</surname><given-names>J.P.</given-names></name></person-group><article-title>Inhibition of <italic>Candida albicans</italic> biofilm formation and modulation of gene expression by probiotic cells and supernatant</article-title><source>J Med Microbiol</source><volume>65</volume><year>2016</year><fpage>328</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.000226</pub-id><pub-id pub-id-type="pmid">26847045</pub-id></element-citation></ref><ref id="b0740"><label>148</label><element-citation publication-type="journal" id="h0740"><person-group person-group-type="author"><name><surname>Allonsius</surname><given-names>C.N.</given-names></name><name><surname>Vandenheuvel</surname><given-names>D.</given-names></name><name><surname>Oerlemans</surname><given-names>E.F.M.</given-names></name><name><surname>Petrova</surname><given-names>M.I.</given-names></name><name><surname>Donders</surname><given-names>G.G.G.</given-names></name><name><surname>Cos</surname><given-names>P.</given-names></name></person-group><article-title>Inhibition of <italic>Candida albicans</italic> morphogenesis by chitinase from <italic>Lactobacillus rhamnosus</italic> GG</article-title><source>Sci Rep</source><volume>9</volume><year>2019</year><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/s41598-019-39625-0</pub-id><pub-id pub-id-type="pmid">30626917</pub-id></element-citation></ref><ref id="b0745"><label>149</label><mixed-citation publication-type="other" id="h0745">Graf K, Last A, Gratz R, Allert S, Linde S, Westermann M, et al. Keeping Candida commensal: How lactobacilli antagonize pathogenicity of Candida albicans in an in vitro gut model. DMM Dis Model Mech 2019;12. https://doi.org/10.1242/dmm.039719.</mixed-citation></ref><ref id="b0750"><label>150</label><element-citation publication-type="journal" id="h0750"><person-group person-group-type="author"><name><surname>Morton</surname><given-names>J.T.</given-names></name><name><surname>Aksenov</surname><given-names>A.A.</given-names></name><name><surname>Nothias</surname><given-names>L.F.</given-names></name><name><surname>Foulds</surname><given-names>J.R.</given-names></name><name><surname>Quinn</surname><given-names>R.A.</given-names></name><name><surname>Badri</surname><given-names>M.H.</given-names></name></person-group><article-title>Learning representations of microbe&#x02013;metabolite interactions</article-title><source>Nat Methods</source><volume>16</volume><year>2019</year><fpage>1306</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1038/s41592-019-0616-3</pub-id><pub-id pub-id-type="pmid">31686038</pub-id></element-citation></ref><ref id="b0755"><label>151</label><element-citation publication-type="journal" id="h0755"><person-group person-group-type="author"><name><surname>Tipton</surname><given-names>L.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>C.L.</given-names></name><name><surname>Kurtz</surname><given-names>Z.D.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Kleerup</surname><given-names>E.</given-names></name><name><surname>Morris</surname><given-names>A.</given-names></name></person-group><article-title>Fungi stabilize connectivity in the lung and skin microbial ecosystems</article-title><source>Microbiome</source><volume>6</volume><year>2018</year><fpage>12</fpage><pub-id pub-id-type="doi">10.1186/s40168-017-0393-0</pub-id><pub-id pub-id-type="pmid">29335027</pub-id></element-citation></ref><ref id="b0760"><label>152</label><element-citation publication-type="journal" id="h0760"><person-group person-group-type="author"><name><surname>Seelbinder</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Brunke</surname><given-names>S.</given-names></name><name><surname>Uribe</surname><given-names>R.V.</given-names></name><name><surname>Santhaman</surname><given-names>R.</given-names></name><name><surname>Meyer</surname><given-names>C.</given-names></name></person-group><article-title>Antibiotics create a shift from mutualism to competition in human gut fungal communities with a longer-lasting impact on fungi than bacteria</article-title><source>Microbiome</source><volume>8</volume><year>2020</year><fpage>1</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1186/s40168-020-00899-6</pub-id><pub-id pub-id-type="pmid">31901242</pub-id></element-citation></ref><ref id="b0765"><label>153</label><element-citation publication-type="journal" id="h0765"><person-group person-group-type="author"><name><surname>Gutierrez</surname><given-names>D.</given-names></name><name><surname>Weinstock</surname><given-names>A.</given-names></name><name><surname>Antharam</surname><given-names>V.C.</given-names></name><name><surname>Gu</surname><given-names>H.</given-names></name><name><surname>Jasbi</surname><given-names>P.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name></person-group><article-title>Antibiotic-induced gut metabolome and microbiome alterations increase the susceptibility to <italic>Candida albicans</italic> colonization in the gastrointestinal tract</article-title><source>FEMS Microbiol Ecol</source><volume>96</volume><year>2020</year><pub-id pub-id-type="doi">10.1093/femsec/fiz187</pub-id></element-citation></ref><ref id="bib766"><label>154</label><element-citation publication-type="journal" id="optrxuRRlAwRm"><person-group person-group-type="author"><name><surname>Moran</surname><given-names>Nancy</given-names></name></person-group><article-title>Microbial minimalism: Genome reduction in bacterial pathogens</article-title><source>Cell</source><volume>108</volume><issue>5</issue><year>2002</year><fpage>583</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00665-7</pub-id><pub-id pub-id-type="pmid">11893328</pub-id></element-citation></ref></ref-list><ack id="ak005"><title>Acknowledgement</title><p id="p0175">RV and BH received funds from the ANR/BMBF 2019 Antimicrobial resistance call, project titled &#x0201c;Antifungal Resistance: From Surveillance to Treatment&#x0201d; (AReST, grant number: 16GW0238K). We thank Dr. Florian Klo&#x000df; (Transfer Group Anti-infectives, Leibniz Institute for Natural Product Research and Infection Biology &#x02013; Hans Knoell Institute, Jena) for reading our manuscript and providing insightful feedback and comments.</p></ack></back></article>